293SLAM rinderpest infection, 00hr, biol_rep1 | 13541-145H4 |
694.08 | 1.75 | 31.17 |
293SLAM rinderpest infection, 00hr, biol_rep2 | 13542-145H5 |
769.01 | 1.62 | 29.54 |
293SLAM rinderpest infection, 00hr, biol_rep3 | 13543-145H6 |
785.51 | 1.93 | 36.84 |
293SLAM rinderpest infection, 06hr, biol_rep1 | 13544-145H7 |
778.42 | 0.62 | 29.32 |
293SLAM rinderpest infection, 06hr, biol_rep2 | 13545-145H8 |
807.85 | 2.47 | 27.22 |
293SLAM rinderpest infection, 06hr, biol_rep3 | 13546-145H9 |
794.24 | 1.74 | 26.16 |
293SLAM rinderpest infection, 12hr, biol_rep1 | 13547-145I1 |
1273.75 | 3.05 | 36.17 |
293SLAM rinderpest infection, 12hr, biol_rep2 | 13548-145I2 |
875.38 | 2.66 | 37.79 |
293SLAM rinderpest infection, 12hr, biol_rep3 | 13549-145I3 |
968.35 | 2.35 | 51.72 |
293SLAM rinderpest infection, 24hr, biol_rep1 | 13550-145I4 |
845.10 | 1.74 | 19.71 |
293SLAM rinderpest infection, 24hr, biol_rep2 | 13551-145I5 |
730.86 | 1.62 | 16.57 |
293SLAM rinderpest infection, 24hr, biol_rep3 | 13552-145I6 |
689.11 | 1.63 | 14.23 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1 | 13625-146H7 |
1418.33 | 0.00 | 6.45 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2 | 13626-146H8 |
1120.11 | 0.30 | 4.81 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3 | 13627-146H9 |
1297.56 | 0.00 | 6.59 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1 | 13628-146I1 |
1105.30 | 0.00 | 6.79 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2 | 13629-146I2 |
1068.23 | 0.22 | 6.33 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3 | 13630-146I3 |
1014.05 | 0.00 | 5.06 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1 | 13631-146I4 |
982.07 | 0.00 | 3.73 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2 | 13632-146I5 |
1645.53 | 0.00 | 8.12 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3 | 13633-146I6 |
1375.14 | 0.00 | 6.15 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1 | 13634-146I7 |
1413.79 | 0.00 | 7.25 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2 | 13635-146I8 |
1117.81 | 0.13 | 4.91 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3 | 13636-146I9 |
1261.87 | 0.00 | 8.74 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1 | 13637-147A1 |
1399.59 | 0.00 | 5.68 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2 | 13638-147A2 |
1443.61 | 0.32 | 6.65 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3 | 13639-147A3 |
1166.50 | 0.00 | 9.89 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1 | 13640-147A4 |
1534.52 | 0.00 | 9.19 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2 | 13641-147A5 |
1416.24 | 0.00 | 8.72 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3 | 13642-147A6 |
1439.22 | 0.18 | 9.95 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1 | 13643-147A7 |
1367.22 | 0.00 | 9.84 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2 | 13644-147A8 |
1565.40 | 0.00 | 11.53 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3 | 13645-147A9 |
1319.35 | 0.00 | 6.54 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1 | 13646-147B1 |
1459.72 | 0.00 | 9.73 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2 | 13647-147B2 |
1536.87 | 0.00 | 9.16 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3 | 13648-147B3 |
1432.19 | 0.00 | 9.96 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1 | 13649-147B4 |
1596.21 | 0.41 | 8.58 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2 | 13650-147B5 |
1187.16 | 0.00 | 10.68 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3 | 13651-147B6 |
1544.45 | 0.27 | 14.32 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1 | 13652-147B7 |
1429.81 | 0.00 | 13.44 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2 | 13653-147B8 |
1309.69 | 0.00 | 7.76 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3 | 13654-147B9 |
1356.93 | 0.15 | 10.54 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1 | 13655-147C1 |
1509.79 | 0.21 | 10.76 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2 | 13656-147C2 |
1468.02 | 0.00 | 10.66 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3 | 13657-147C3 |
1577.47 | 0.00 | 15.86 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1 | 13658-147C4 |
1670.17 | 0.23 | 13.73 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2 | 13659-147C5 |
1376.10 | 0.00 | 11.28 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3 | 13660-147C6 |
1754.92 | 0.00 | 12.22 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1 | 13661-147C7 |
1434.33 | 0.00 | 10.29 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2 | 13662-147C8 |
1605.45 | 0.00 | 11.73 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3 | 13663-147C9 |
1206.15 | 0.00 | 19.27 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1 | 13664-147D1 |
1419.42 | 0.00 | 15.57 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2 | 13665-147D2 |
671.62 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3 | 13666-147D3 |
885.37 | 0.35 | 12.77 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1 | 13667-147D4 |
789.36 | 0.00 | 18.56 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2 | 13668-147D5 |
648.50 | 0.00 | 24.33 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3 | 13669-147D6 |
1053.04 | 0.00 | 29.85 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1 | 13670-147D7 |
774.62 | 0.00 | 14.58 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2 | 13671-147D8 |
818.02 | 0.00 | 8.35 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3 | 13672-147D9 |
1579.20 | 0.00 | 22.63 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2 | 13674-147E2 |
773.44 | 0.00 | 16.22 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3 | 13675-147E3 |
665.66 | 0.00 | 18.51 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1 | 13676-147E4 |
889.29 | 0.00 | 23.88 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2 | 13677-147E5 |
1218.07 | 0.00 | 23.44 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3 | 13678-147E6 |
787.61 | 0.00 | 13.32 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1 | 13679-147E7 |
648.19 | 0.00 | 9.58 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2 | 13680-147E8 |
339.44 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3 | 13681-147E9 |
355.39 | 0.00 | 39.49 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1 | 13682-147F1 |
544.07 | 0.00 | 12.19 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2 | 13683-147F2 |
603.48 | 0.00 | 10.41 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3 | 13684-147F3 |
595.31 | 0.00 | 14.07 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1 | 13685-147F4 |
1018.07 | 0.00 | 17.55 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2 | 13686-147F5 |
619.30 | 0.00 | 9.59 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3 | 13687-147F6 |
624.02 | 0.00 | 7.95 |
Adipocyte - breast, donor1 | 11376-118A8 |
501.92 | 0.00 | 4.43 |
Adipocyte - breast, donor2 | 11327-117E4 |
448.07 | 0.00 | 4.49 |
Adipocyte - omental, donor1 | 11473-119C6 |
416.54 | 0.00 | 3.31 |
Adipocyte - omental, donor2 | 11474-119C7 |
700.40 | 0.00 | 13.45 |
Adipocyte - omental, donor3 | 11475-119C8 |
624.96 | 0.00 | 10.05 |
Adipocyte - perirenal, donor1 | 11476-119C9 |
856.18 | 0.00 | 15.31 |
Adipocyte - subcutaneous, donor1 | 11259-116F8 |
908.19 | 0.00 | 11.00 |
Adipocyte - subcutaneous, donor2 | 11336-117F4 |
810.21 | 0.00 | 26.65 |
Adipocyte - subcutaneous, donor3 | 11408-118E4 |
1151.79 | 0.17 | 5.04 |
Adipocyte differentiation, day04, donor1 | 13019-139D4 |
557.97 | 0.00 | 4.89 |
Adipocyte differentiation, day04, donor2 | 13022-139D7 |
471.78 | 0.00 | 6.69 |
Adipocyte differentiation, day04, donor3 | 13025-139E1 |
538.31 | 0.00 | 9.20 |
Adipocyte differentiation, day04, donor4 | 13028-139E4 |
518.45 | 0.00 | 5.88 |
Adipocyte differentiation, day08, donor1 | 13020-139D5 |
461.85 | 0.00 | 4.75 |
Adipocyte differentiation, day08, donor2 | 13023-139D8 |
500.92 | 0.00 | 9.68 |
Adipocyte differentiation, day08, donor3 | 13026-139E2 |
415.89 | 0.00 | 1.60 |
Adipocyte differentiation, day08, donor4 | 13029-139E5 |
434.02 | 0.00 | 1.67 |
Adipocyte differentiation, day12, donor1 | 13021-139D6 |
516.12 | 0.00 | 9.98 |
Adipocyte differentiation, day12, donor2 | 13024-139D9 |
384.79 | 0.00 | 6.53 |
Adipocyte differentiation, day12, donor3 | 13027-139E3 |
368.48 | 0.00 | 5.89 |
Adipocyte differentiation, day12, donor4 | 13030-139E6 |
267.63 | 0.00 | 3.04 |
Alveolar Epithelial Cells, donor1 | 11510-119G7 |
1037.58 | 0.00 | 37.79 |
Alveolar Epithelial Cells, donor2 | 11590-120G6 |
3212.53 | 0.00 | 78.89 |
Alveolar Epithelial Cells, donor3 | 11671-122G6 |
1354.96 | 0.00 | 7.19 |
Amniotic Epithelial Cells, donor1 | 11533-120A3 |
818.03 | 0.18 | 20.33 |
Amniotic Epithelial Cells, donor2 | 11613-122A2 |
1293.61 | 0.00 | 18.41 |
Amniotic Epithelial Cells, donor3 | 11694-123A2 |
1142.70 | 0.00 | 10.68 |
Anulus Pulposus Cell, donor1 | 11248-116E6 |
824.44 | 0.11 | 2.86 |
Anulus Pulposus Cell, donor2 | 11463-119B5 |
1004.61 | 0.00 | 7.10 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1) | 12642-134G5 |
728.76 | 0.00 | 11.68 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2) | 12740-135I4 |
768.43 | 0.43 | 9.12 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3) | 12838-137B3 |
1097.95 | 0.00 | 6.42 |
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4) | 12643-134G6 |
723.99 | 0.30 | 12.85 |
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5) | 12741-135I5 |
876.40 | 0.00 | 15.18 |
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6) | 12839-137B4 |
1007.27 | 0.00 | 5.28 |
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7) | 12644-134G7 |
706.95 | 0.00 | 12.02 |
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8) | 12742-135I6 |
781.56 | 0.00 | 15.05 |
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9) | 12840-137B5 |
944.27 | 0.00 | 7.13 |
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10) | 12645-134G8 |
749.88 | 0.38 | 16.20 |
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11) | 12743-135I7 |
791.71 | 0.00 | 13.06 |
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12) | 12841-137B6 |
1008.04 | 0.00 | 15.05 |
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13) | 12646-134G9 |
687.11 | 0.33 | 4.45 |
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14) | 12744-135I8 |
738.36 | 0.00 | 10.92 |
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15) | 12842-137B7 |
889.06 | 0.00 | 12.21 |
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16) | 12647-134H1 |
749.57 | 0.00 | 15.00 |
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17) | 12745-135I9 |
821.30 | 0.00 | 9.82 |
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18) | 12843-137B8 |
844.89 | 0.00 | 6.95 |
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19) | 12648-134H2 |
683.79 | 0.00 | 7.80 |
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20) | 12746-136A1 |
774.90 | 0.00 | 13.43 |
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21) | 12844-137B9 |
967.78 | 0.00 | 3.60 |
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22) | 12649-134H3 |
768.21 | 0.00 | 3.54 |
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23) | 12747-136A2 |
760.91 | 0.00 | 10.29 |
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24) | 12845-137C1 |
1052.94 | 0.00 | 8.39 |
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25) | 12650-134H4 |
774.25 | 0.00 | 13.11 |
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26) | 12748-136A3 |
878.81 | 0.00 | 12.90 |
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27) | 12846-137C2 |
986.05 | 0.00 | 10.90 |
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28) | 12651-134H5 |
759.29 | 0.00 | 20.52 |
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29) | 12749-136A4 |
838.64 | 0.00 | 8.98 |
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30) | 12847-137C3 |
916.99 | 0.00 | 8.00 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31) | 12652-134H6 |
782.17 | 0.00 | 15.48 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32) | 12750-136A5 |
805.80 | 0.00 | 9.65 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33) | 12848-137C4 |
1097.29 | 0.00 | 9.27 |
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34) | 12653-134H7 |
795.53 | 0.00 | 14.04 |
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35) | 12751-136A6 |
883.35 | 0.00 | 6.32 |
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36) | 12849-137C5 |
1163.04 | 0.00 | 9.50 |
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37) | 12654-134H8 |
896.59 | 0.00 | 11.70 |
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38) | 12752-136A7 |
945.66 | 0.00 | 11.46 |
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39) | 12850-137C6 |
1090.93 | 0.00 | 9.53 |
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40) | 12655-134H9 |
803.08 | 0.00 | 14.24 |
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41) | 12753-136A8 |
867.49 | 0.00 | 12.49 |
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42) | 12851-137C7 |
912.86 | 0.00 | 8.12 |
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43) | 12656-134I1 |
692.49 | 0.00 | 4.72 |
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44) | 12754-136A9 |
866.78 | 0.00 | 12.88 |
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45) | 12852-137C8 |
1172.08 | 0.00 | 9.27 |
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46) | 12657-134I2 |
720.39 | 0.00 | 14.79 |
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47) | 12755-136B1 |
732.65 | 0.00 | 11.15 |
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48) | 12853-137C9 |
1052.91 | 0.00 | 7.82 |
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49) | 12658-134I3 |
740.64 | 0.00 | 17.50 |
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50) | 12756-136B2 |
886.88 | 0.00 | 11.03 |
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51) | 12854-137D1 |
992.07 | 0.00 | 7.65 |
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52) | 12659-134I4 |
966.08 | 0.00 | 12.71 |
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53) | 12757-136B3 |
868.08 | 0.21 | 8.26 |
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54) | 12855-137D2 |
926.87 | 0.00 | 9.49 |
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55) | 12660-134I5 |
701.72 | 0.00 | 12.91 |
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56) | 12758-136B4 |
818.00 | 0.00 | 9.09 |
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57) | 12856-137D3 |
1161.13 | 0.00 | 7.63 |
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58) | 12661-134I6 |
774.89 | 0.00 | 13.85 |
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59) | 12759-136B5 |
777.70 | 0.26 | 12.18 |
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60) | 12857-137D4 |
914.80 | 0.00 | 6.18 |
Astrocyte - cerebellum, donor1 | 11500-119F6 |
1454.88 | 0.12 | 20.76 |
Astrocyte - cerebellum, donor2 | 11580-120F5 |
2142.41 | 0.00 | 41.93 |
Astrocyte - cerebellum, donor3 | 11661-122F5 |
1462.36 | 0.21 | 10.28 |
Astrocyte - cerebral cortex, donor1 | 11235-116D2 |
913.99 | 0.00 | 9.76 |
Astrocyte - cerebral cortex, donor2 | 11316-117D2 |
1174.31 | 0.00 | 13.75 |
Astrocyte - cerebral cortex, donor3 | 11392-118C6 |
1038.45 | 0.15 | 18.94 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1 | 10821-111C2 |
1665.46 | 0.23 | 12.73 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2 | 10822-111C3 |
1642.94 | 0.25 | 18.54 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3 | 10823-111C4 |
1570.05 | 0.11 | 12.29 |
Basophils, donor1 | 12241-129G9 |
734.65 | 0.00 | 3.66 |
Basophils, donor2 | 12242-129H1 |
1064.35 | 0.00 | 3.25 |
Basophils, donor3 | 12243-129H2 |
575.05 | 0.00 | 1.91 |
Bronchial Epithelial Cell, donor1 | 11511-119G8 |
1111.43 | 0.43 | 15.09 |
Bronchial Epithelial Cell, donor2 | 11591-120G7 |
2744.49 | 0.00 | 21.94 |
Bronchial Epithelial Cell, donor3 | 11672-122G7 |
2209.46 | 0.00 | 0.00 |
Bronchial Epithelial Cell, donor4 | 11453-119A4 |
2494.92 | 0.00 | 40.80 |
Bronchial Epithelial Cell, donor5 | 11457-119A8 |
1686.06 | 0.00 | 23.71 |
Bronchial Epithelial Cell, donor6 | 11461-119B3 |
866.81 | 0.23 | 5.07 |
Bronchial Epithelial Cell, donor7 | 11769-123I5 |
945.97 | 0.00 | 10.98 |
Burkitt's lymphoma cell line:DAUDI | 10422-106C8 |
1959.18 | 1.13 | 18.96 |
Burkitt's lymphoma cell line:RAJI | 10476-106I8 |
2337.42 | 0.47 | 20.50 |
CD133+ stem cells - adult bone marrow derived, pool1 | 12224-129F1 |
3671.98 | 0.00 | 15.03 |
CD133+ stem cells - cord blood derived, pool1 | 12223-129E9 |
3826.52 | 0.00 | 31.03 |
CD14+ Monocytes, donor1 | 11224-116B9 |
566.37 | 0.00 | 2.25 |
CD14+ Monocytes, donor2 | 11305-117B9 |
483.12 | 0.00 | 1.11 |
CD14+ Monocytes, donor3 | 11381-118B4 |
625.24 | 0.00 | 1.10 |
CD14+ monocyte derived endothelial progenitor cells, donor1 | 11229-116C5 |
457.97 | 0.00 | 0.85 |
CD14+ monocyte derived endothelial progenitor cells, donor2 | 11310-117C5 |
543.21 | 0.00 | 0.76 |
CD14+ monocyte derived endothelial progenitor cells, donor3 | 11386-118B9 |
448.07 | 0.00 | 3.29 |
CD14+ monocytes - mock treated, donor1 | 11863-125A9 |
455.33 | 0.00 | 1.59 |
CD14+ monocytes - mock treated, donor2 | 11873-125C1 |
445.67 | 0.00 | 3.32 |
CD14+ monocytes - mock treated, donor3 | 11883-125D2 |
399.64 | 0.00 | 2.61 |
CD14+ monocytes - treated with B-glucan, donor1 | 11869-125B6 |
396.06 | 0.00 | 1.00 |
CD14+ monocytes - treated with B-glucan, donor2 | 11879-125C7 |
382.28 | 0.00 | 3.04 |
CD14+ monocytes - treated with B-glucan, donor3 | 11889-125D8 |
409.08 | 0.00 | 3.72 |
CD14+ monocytes - treated with BCG, donor1 | 11860-125A6 |
399.04 | 0.00 | 1.57 |
CD14+ monocytes - treated with BCG, donor2 | 11870-125B7 |
549.28 | 0.00 | 2.14 |
CD14+ monocytes - treated with BCG, donor3 | 11880-125C8 |
611.98 | 0.00 | 4.13 |
CD14+ monocytes - treated with Candida, donor1 | 11868-125B5 |
447.42 | 0.00 | 0.47 |
CD14+ monocytes - treated with Candida, donor2 | 11878-125C6 |
514.83 | 0.00 | 1.58 |
CD14+ monocytes - treated with Candida, donor3 | 11888-125D7 |
447.07 | 0.00 | 3.33 |
CD14+ monocytes - treated with Cryptococcus, donor1 | 11867-125B4 |
388.68 | 0.00 | 0.30 |
CD14+ monocytes - treated with Cryptococcus, donor2 | 11877-125C5 |
391.11 | 0.00 | 2.99 |
CD14+ monocytes - treated with Cryptococcus, donor3 | 11887-125D6 |
553.39 | 0.00 | 4.79 |
CD14+ monocytes - treated with Group A streptococci, donor1 | 11864-125B1 |
485.71 | 0.00 | 1.14 |
CD14+ monocytes - treated with Group A streptococci, donor2 | 11874-125C2 |
475.48 | 0.00 | 3.17 |
CD14+ monocytes - treated with Group A streptococci, donor3 | 11884-125D3 |
348.73 | 0.00 | 4.36 |
CD14+ monocytes - treated with IFN + N-hexane, donor1 | 11861-125A7 |
445.99 | 0.00 | 1.34 |
CD14+ monocytes - treated with IFN + N-hexane, donor2 | 11871-125B8 |
600.14 | 0.00 | 1.74 |
CD14+ monocytes - treated with IFN + N-hexane, donor3 | 11881-125C9 |
522.66 | 0.00 | 6.31 |
CD14+ monocytes - treated with Salmonella, donor1 | 11866-125B3 |
410.41 | 0.00 | 0.92 |
CD14+ monocytes - treated with Salmonella, donor2 | 11876-125C4 |
422.72 | 0.00 | 2.11 |
CD14+ monocytes - treated with Salmonella, donor3 | 11886-125D5 |
318.95 | 0.00 | 2.19 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1 | 11862-125A8 |
382.93 | 0.17 | 1.22 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2 | 11872-125B9 |
428.54 | 0.00 | 2.97 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3 | 11882-125D1 |
610.00 | 0.00 | 4.53 |
CD14+ monocytes - treated with lipopolysaccharide, donor1 | 11865-125B2 |
456.17 | 0.00 | 1.23 |
CD14+ monocytes - treated with lipopolysaccharide, donor2 | 11875-125C3 |
439.95 | 0.00 | 2.09 |
CD14+ monocytes - treated with lipopolysaccharide, donor3 | 11885-125D4 |
509.45 | 0.00 | 4.87 |
CD14+CD16+ Monocytes, donor1 | 11789-124B7 |
743.69 | 0.22 | 9.15 |
CD14+CD16+ Monocytes, donor2 | 11801-124D1 |
801.32 | 0.00 | 4.16 |
CD14+CD16+ Monocytes, donor3 | 11912-125G4 |
775.27 | 0.00 | 9.10 |
CD14+CD16- Monocytes, donor1 | 11788-124B6 |
861.45 | 0.00 | 3.11 |
CD14+CD16- Monocytes, donor2 | 11799-124C8 |
628.89 | 0.00 | 4.19 |
CD14+CD16- Monocytes, donor3 | 11910-125G2 |
501.68 | 0.00 | 7.58 |
CD14-CD16+ Monocytes, donor1 | 11790-124B8 |
1184.27 | 0.00 | 3.32 |
CD14-CD16+ Monocytes, donor2 | 11800-124C9 |
703.49 | 0.00 | 3.73 |
CD14-CD16+ Monocytes, donor3 | 11911-125G3 |
822.60 | 0.00 | 8.21 |
CD19+ B Cells (pluriselect), donor090309, donation1 | 12189-129B2 |
4013.81 | 0.00 | 0.00 |
CD19+ B Cells (pluriselect), donor090309, donation2 | 12194-129B7 |
3362.10 | 0.00 | 7.46 |
CD19+ B Cells (pluriselect), donor090309, donation3 | 12199-129C3 |
3889.70 | 0.00 | 4.14 |
CD19+ B Cells (pluriselect), donor090325, donation1 | 12151-128F9 |
3657.71 | 0.00 | 8.53 |
CD19+ B Cells (pluriselect), donor090325, donation2 | 12174-128I5 |
4022.65 | 0.00 | 4.82 |
CD19+ B Cells (pluriselect), donor090612, donation1 | 12204-129C8 |
3508.29 | 0.00 | 6.32 |
CD19+ B Cells (pluriselect), donor090612, donation2 | 12209-129D4 |
3809.61 | 0.00 | 3.92 |
CD19+ B Cells (pluriselect), donor090612, donation3 | 12214-129D9 |
4596.86 | 1.32 | 2.64 |
CD19+ B Cells, donor1 | 11544-120B5 |
1724.35 | 0.00 | 6.58 |
CD19+ B Cells, donor2 | 11624-122B4 |
1642.37 | 0.00 | 4.35 |
CD19+ B Cells, donor3 | 11705-123B4 |
1446.83 | 0.00 | 7.57 |
CD34 cells differentiated to erythrocyte lineage, biol_ rep1 | 11931-125I5 |
1143.08 | 0.40 | 25.05 |
CD34 cells differentiated to erythrocyte lineage, biol_ rep2 | 11932-125I6 |
1123.77 | 0.80 | 22.77 |
CD34+ Progenitors, donor1 | 11545-120B6 |
2457.91 | 0.00 | 2.01 |
CD34+ Progenitors, donor2 | 11625-122B5 |
2350.60 | 0.00 | 2.81 |
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1 | 12225-129F2 |
2584.82 | 0.38 | 16.91 |
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2 | 12225-129F2 |
2989.68 | 0.00 | 21.65 |
CD4+ T Cells, donor1 | 11225-116C1 |
1696.38 | 0.00 | 3.57 |
CD4+ T Cells, donor2 | 11306-117C1 |
2494.77 | 0.00 | 1.84 |
CD4+ T Cells, donor3 | 11382-118B5 |
2161.79 | 0.00 | 4.88 |
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1 | 11793-124C2 |
1093.18 | 0.00 | 9.95 |
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2 | 11915-125G7 |
1304.24 | 0.00 | 5.61 |
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3 | 11919-125H2 |
1221.42 | 0.00 | 4.89 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor1 | 11780-124A7 |
4489.64 | 0.00 | 13.27 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor2 | 11796-124C5 |
5683.19 | 0.00 | 14.75 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor3 | 11907-125F8 |
3800.55 | 0.00 | 16.48 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1 | 11794-124C3 |
831.54 | 0.00 | 6.07 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2 | 11916-125G8 |
1102.86 | 0.00 | 8.47 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3 | 11920-125H3 |
1016.89 | 0.00 | 6.93 |
CD4+CD25+CD45RA- memory regulatory T cells, donor1 | 11782-124A9 |
1800.37 | 0.45 | 8.07 |
CD4+CD25+CD45RA- memory regulatory T cells, donor2 | 11797-124C6 |
2039.73 | 0.00 | 7.69 |
CD4+CD25+CD45RA- memory regulatory T cells, donor3 | 11908-125F9 |
1574.69 | 0.00 | 11.88 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1 | 11791-124B9 |
1198.73 | 0.00 | 5.48 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2 | 11913-125G5 |
1437.77 | 0.00 | 6.44 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3 | 11917-125G9 |
1779.23 | 0.00 | 5.68 |
CD4+CD25-CD45RA+ naive conventional T cells, donor1 | 11784-124B2 |
3159.06 | 0.00 | 5.44 |
CD4+CD25-CD45RA+ naive conventional T cells, donor2 | 11795-124C4 |
2998.10 | 0.00 | 8.58 |
CD4+CD25-CD45RA+ naive conventional T cells, donor3 | 11906-125F7 |
2818.95 | 0.00 | 10.76 |
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1 | 11792-124C1 |
1129.44 | 0.00 | 10.20 |
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2 | 11914-125G6 |
1032.83 | 0.00 | 12.13 |
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3 | 11918-125H1 |
949.89 | 0.00 | 9.46 |
CD4+CD25-CD45RA- memory conventional T cells, donor1 | 11786-124B4 |
3342.55 | 0.00 | 7.58 |
CD4+CD25-CD45RA- memory conventional T cells, donor2 | 11798-124C7 |
3275.81 | 0.00 | 9.96 |
CD4+CD25-CD45RA- memory conventional T cells, donor3 | 11909-125G1 |
1880.98 | 0.00 | 16.13 |
CD8+ T Cells (pluriselect), donor090309, donation1 | 12186-129A8 |
4099.50 | 0.00 | 7.42 |
CD8+ T Cells (pluriselect), donor090309, donation2 | 12191-129B4 |
3933.69 | 0.00 | 9.23 |
CD8+ T Cells (pluriselect), donor090309, donation3 | 12196-129B9 |
4468.03 | 0.00 | 9.77 |
CD8+ T Cells (pluriselect), donor090325, donation1 | 12148-128F6 |
3407.61 | 0.00 | 6.09 |
CD8+ T Cells (pluriselect), donor090325, donation2 | 12171-128I2 |
3532.65 | 0.00 | 13.01 |
CD8+ T Cells (pluriselect), donor090612, donation1 | 12201-129C5 |
3469.63 | 0.00 | 7.70 |
CD8+ T Cells (pluriselect), donor090612, donation2 | 12206-129D1 |
3309.01 | 0.00 | 6.80 |
CD8+ T Cells (pluriselect), donor090612, donation3 | 12211-129D6 |
4480.45 | 0.00 | 11.08 |
CD8+ T Cells, donor1 | 11226-116C2 |
1351.16 | 0.33 | 4.26 |
CD8+ T Cells, donor2 | 11307-117C2 |
1719.85 | 0.00 | 4.51 |
CD8+ T Cells, donor3 | 11383-118B6 |
1964.62 | 0.00 | 5.05 |
COBL-a rinderpest infection, 00hr, biol_rep1 | 13553-145I7 |
667.99 | 0.00 | 16.29 |
COBL-a rinderpest infection, 00hr, biol_rep2 | 13554-145I8 |
597.91 | 0.00 | 14.14 |
COBL-a rinderpest infection, 00hr, biol_rep3 | 13555-145I9 |
766.33 | 0.00 | 9.58 |
COBL-a rinderpest infection, 06hr, biol_rep1 | 13556-146A1 |
666.47 | 0.00 | 35.12 |
COBL-a rinderpest infection, 06hr, biol_rep2 | 13557-146A2 |
566.60 | 0.48 | 11.28 |
COBL-a rinderpest infection, 06hr, biol_rep3 | 13558-146A3 |
616.44 | 0.00 | 13.87 |
COBL-a rinderpest infection, 12hr, biol_rep1 | 13559-146A4 |
684.01 | 0.00 | 28.90 |
COBL-a rinderpest infection, 12hr, biol_rep2 | 13560-146A5 |
639.06 | 0.00 | 23.69 |
COBL-a rinderpest infection, 12hr, biol_rep3 | 13561-146A6 |
650.08 | 0.23 | 23.92 |
COBL-a rinderpest infection, 24hr, biol_rep1 | 13562-146A7 |
766.47 | 0.30 | 29.89 |
COBL-a rinderpest infection, 24hr, biol_rep2 | 13563-146A8 |
820.97 | 0.00 | 22.66 |
COBL-a rinderpest infection, 24hr, biol_rep3 | 13564-146A9 |
738.82 | 0.00 | 23.18 |
COBL-a rinderpest infection, 48hr, biol_rep1 | 13565-146B1 |
445.63 | 0.44 | 4.82 |
COBL-a rinderpest infection, 48hr, biol_rep2 | 13566-146B2 |
491.86 | 0.46 | 9.11 |
COBL-a rinderpest infection, 48hr, biol_rep3 | 13567-146B3 |
443.79 | 0.00 | 6.71 |
COBL-a rinderpest(-C) infection, 06hr, biol_rep1 | 13568-146B4 |
614.06 | 0.36 | 14.05 |
COBL-a rinderpest(-C) infection, 06hr, biol_rep2 | 13569-146B5 |
704.92 | 0.58 | 13.52 |
COBL-a rinderpest(-C) infection, 06hr, biol_rep3 | 13570-146B6 |
799.25 | 0.00 | 8.49 |
COBL-a rinderpest(-C) infection, 12hr, biol_rep1 | 13571-146B7 |
611.31 | 0.00 | 21.23 |
COBL-a rinderpest(-C) infection, 12hr, biol_rep2 | 13572-146B8 |
750.15 | 0.00 | 19.07 |
COBL-a rinderpest(-C) infection, 12hr, biol_rep3 | 13573-146B9 |
633.79 | 0.00 | 25.01 |
COBL-a rinderpest(-C) infection, 24hr, biol_rep1 | 13574-146C1 |
689.59 | 0.00 | 21.04 |
COBL-a rinderpest(-C) infection, 24hr, biol_rep2 | 13575-146C2 |
680.22 | 0.39 | 14.19 |
COBL-a rinderpest(-C) infection, 24hr, biol_rep3 | 13576-146C3 |
702.71 | 0.00 | 17.40 |
COBL-a rinderpest(-C) infection, 48hr, biol_rep1 | 13577-146C4 |
460.09 | 0.00 | 5.62 |
COBL-a rinderpest(-C) infection, 48hr, biol_rep2 | 13578-146C5 |
581.92 | 0.00 | 7.69 |
COBL-a rinderpest(-C) infection, 48hr, biol_rep3 | 13579-146C6 |
449.79 | 0.00 | 1.00 |
Cardiac Myocyte, donor1 | 11525-119I4 |
244.92 | 0.00 | 9.14 |
Cardiac Myocyte, donor2 | 11605-120I3 |
824.64 | 0.00 | 20.75 |
Cardiac Myocyte, donor3 | 11686-122I3 |
907.00 | 0.00 | 10.52 |
Chondrocyte - de diff, donor1 | 11261-116G1 |
921.09 | 0.00 | 7.97 |
Chondrocyte - de diff, donor2 | 11338-117F6 |
657.45 | 0.00 | 14.22 |
Chondrocyte - de diff, donor3 | 11410-118E6 |
744.34 | 0.00 | 4.21 |
Chondrocyte - re diff, donor2 | 11339-117F7 |
541.63 | 0.00 | 25.07 |
Chondrocyte - re diff, donor3 | 11411-118E7 |
686.27 | 0.00 | 2.83 |
Ciliary Epithelial Cells, donor1 | 11242-116D9 |
986.92 | 0.00 | 4.93 |
Ciliary Epithelial Cells, donor2 | 11323-117D9 |
1020.73 | 0.00 | 9.83 |
Ciliary Epithelial Cells, donor3 | 11399-118D4 |
945.69 | 0.00 | 13.72 |
Clontech Human Universal Reference Total RNA, pool1 | 10000-101A1 |
518.75 | 0.00 | 2.38 |
Corneal Epithelial Cells, donor1 | 11526-119I5 |
1124.21 | 0.22 | 17.13 |
Corneal Epithelial Cells, donor2 | 11606-120I4 |
1729.15 | 0.00 | 32.99 |
Corneal Epithelial Cells, donor3 | 11687-122I4 |
1786.09 | 0.26 | 29.14 |
Dendritic Cells - monocyte immature derived, donor1, rep2 | 11227-116C3 |
244.67 | 0.00 | 4.62 |
Dendritic Cells - monocyte immature derived, donor1, tech_rep1 | 11227-116C3 |
254.54 | 0.00 | 7.25 |
Dendritic Cells - monocyte immature derived, donor2 | 11308-117C3 |
469.30 | 0.00 | 6.90 |
Dendritic Cells - monocyte immature derived, donor3 | 11384-118B7 |
265.55 | 0.00 | 7.78 |
Dendritic Cells - plasmacytoid, donor1 | 11228-116C4 |
1316.69 | 0.00 | 4.44 |
Dendritic Cells - plasmacytoid, donor2 | 11309-117C4 |
2594.51 | 0.00 | 12.40 |
Dendritic Cells - plasmacytoid, donor3 | 11385-118B8 |
2292.93 | 0.00 | 9.19 |
Endothelial Cells - Aortic, donor0 | 11207-116A1 |
907.89 | 0.00 | 17.68 |
Endothelial Cells - Aortic, donor1 | 11263-116G3 |
944.12 | 0.00 | 44.01 |
Endothelial Cells - Aortic, donor2 | 11340-117F8 |
766.38 | 0.28 | 26.58 |
Endothelial Cells - Aortic, donor3 | 11412-118E8 |
1031.32 | 0.00 | 6.29 |
Endothelial Cells - Artery, donor1 | 11264-116G4 |
710.90 | 0.00 | 27.92 |
Endothelial Cells - Artery, donor2 | 11341-117F9 |
703.48 | 0.00 | 14.82 |
Endothelial Cells - Artery, donor3 | 11413-118E9 |
923.00 | 0.00 | 24.54 |
Endothelial Cells - Lymphatic, donor1 | 11236-116D3 |
483.87 | 0.00 | 3.55 |
Endothelial Cells - Lymphatic, donor2 | 11317-117D3 |
426.89 | 0.00 | 2.13 |
Endothelial Cells - Lymphatic, donor3 | 11393-118C7 |
263.02 | 0.00 | 3.95 |
Endothelial Cells - Microvascular, donor1 | 11265-116G5 |
1043.24 | 0.00 | 12.18 |
Endothelial Cells - Microvascular, donor2 | 11342-117G1 |
1038.73 | 0.52 | 22.39 |
Endothelial Cells - Microvascular, donor3 | 11414-118F1 |
872.56 | 0.00 | 7.94 |
Endothelial Cells - Thoracic, donor1 | 11266-116G6 |
1021.51 | 0.00 | 20.81 |
Endothelial Cells - Thoracic, donor2 | 11343-117G2 |
989.55 | 0.00 | 13.63 |
Endothelial Cells - Umbilical vein, donor1 | 11243-116E1 |
709.45 | 0.25 | 9.57 |
Endothelial Cells - Umbilical vein, donor2 | 11324-117E1 |
732.82 | 0.00 | 18.03 |
Endothelial Cells - Umbilical vein, donor3 | 11400-118D5 |
771.85 | 0.00 | 22.72 |
Endothelial Cells - Vein, donor1 | 11267-116G7 |
880.43 | 0.00 | 55.74 |
Endothelial Cells - Vein, donor2 | 11344-117G3 |
544.83 | 0.00 | 23.05 |
Endothelial Cells - Vein, donor3 | 11416-118F3 |
1015.36 | 0.16 | 23.55 |
Eosinophils, donor1 | 12244-129H3 |
2165.06 | 0.00 | 0.00 |
Eosinophils, donor2 | 12245-129H4 |
311.90 | 0.00 | 3.30 |
Eosinophils, donor3 | 12246-129H5 |
281.78 | 0.00 | 0.00 |
Esophageal Epithelial Cells, donor1 | 11507-119G4 |
914.02 | 0.24 | 23.46 |
Esophageal Epithelial Cells, donor2 | 11587-120G3 |
1999.04 | 0.00 | 12.48 |
Esophageal Epithelial Cells, donor3 | 11668-122G3 |
1317.77 | 0.00 | 0.00 |
Ewing's sarcoma cell line:Hs 863.T | 10705-109H3 |
576.77 | 0.00 | 7.39 |
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction) | 14331-155F2 |
569.23 | 0.22 | 13.58 |
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction) | 14310-155C8 |
1325.62 | 0.00 | 23.08 |
Fibroblast - Aortic Adventitial, donor1 | 11245-116E3 |
708.27 | 0.12 | 7.16 |
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction) | 14332-155F3 |
228.32 | 0.00 | 3.55 |
Fibroblast - Aortic Adventitial, donor2 | 11326-117E3 |
606.24 | 0.11 | 6.43 |
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction) | 14311-155C9 |
213.69 | 0.00 | 8.17 |
Fibroblast - Aortic Adventitial, donor3 | 11401-118D6 |
738.81 | 0.00 | 21.59 |
Fibroblast - Cardiac, donor1 | 11268-116G8 |
868.70 | 0.00 | 29.49 |
Fibroblast - Cardiac, donor2 | 11345-117G4 |
417.63 | 0.00 | 10.61 |
Fibroblast - Cardiac, donor3 | 11417-118F4 |
934.00 | 0.00 | 12.14 |
Fibroblast - Cardiac, donor4 | 11452-119A3 |
513.46 | 0.00 | 5.15 |
Fibroblast - Cardiac, donor5 | 11456-119A7 |
918.79 | 0.00 | 11.68 |
Fibroblast - Cardiac, donor6 | 11460-119B2 |
1080.56 | 0.00 | 20.47 |
Fibroblast - Choroid Plexus, donor1 | 11492-119E7 |
883.40 | 0.00 | 9.92 |
Fibroblast - Choroid Plexus, donor2 | 11572-120E6 |
465.51 | 0.00 | 11.65 |
Fibroblast - Choroid Plexus, donor3 | 11653-122E6 |
1076.62 | 0.00 | 19.04 |
Fibroblast - Conjunctival, donor1 | 11531-120A1 |
1097.38 | 0.00 | 24.68 |
Fibroblast - Conjunctival, donor3 | 11692-122I9 |
944.87 | 0.00 | 1.19 |
Fibroblast - Dermal, donor1 | 11269-116G9 |
1101.59 | 0.70 | 33.81 |
Fibroblast - Dermal, donor2 | 11346-117G5 |
1224.01 | 0.47 | 37.73 |
Fibroblast - Dermal, donor3 | 11418-118F5 |
1339.42 | 0.36 | 13.78 |
Fibroblast - Dermal, donor4 | 11450-119A1 |
1140.29 | 0.00 | 20.46 |
Fibroblast - Dermal, donor5 | 11454-119A5 |
1288.51 | 0.00 | 28.26 |
Fibroblast - Dermal, donor6 | 11458-119A9 |
1413.90 | 0.00 | 34.92 |
Fibroblast - Gingival, donor1 | 11237-116D4 |
668.83 | 0.00 | 4.79 |
Fibroblast - Gingival, donor10 (periodontitis) | 11928-125I2 |
736.22 | 0.26 | 8.38 |
Fibroblast - Gingival, donor2 | 11318-117D4 |
1052.82 | 0.00 | 11.47 |
Fibroblast - Gingival, donor3 | 11394-118C8 |
659.31 | 0.19 | 3.77 |
Fibroblast - Gingival, donor4 (GFH2) | 11222-116B7 |
527.76 | 0.00 | 3.12 |
Fibroblast - Gingival, donor5 (GFH3) | 11303-117B7 |
515.40 | 0.00 | 2.11 |
Fibroblast - Gingival, donor6 (aggressive periodontitis) | 11921-125H4 |
1080.83 | 0.16 | 14.81 |
Fibroblast - Gingival, donor6 (control) | 11922-125H5 |
1012.99 | 0.27 | 12.04 |
Fibroblast - Gingival, donor7 (aggressive periodontitis) | 11923-125H6 |
189.50 | 0.00 | 2.47 |
Fibroblast - Gingival, donor7 (control) | 11924-125H7 |
1073.43 | 0.00 | 10.82 |
Fibroblast - Gingival, donor8 (chronic periodontitis) | 11925-125H8 |
956.52 | 0.00 | 11.59 |
Fibroblast - Gingival, donor8 (control) | 11926-125H9 |
1077.41 | 0.00 | 21.39 |
Fibroblast - Gingival, donor9 (control) | 11927-125I1 |
819.98 | 0.00 | 3.52 |
Fibroblast - Lung, donor1 | 11270-116H1 |
784.34 | 0.00 | 27.19 |
Fibroblast - Lung, donor2 | 11347-117G6 |
632.67 | 0.00 | 4.48 |
Fibroblast - Lung, donor3 | 11419-118F6 |
1008.12 | 0.00 | 13.30 |
Fibroblast - Lymphatic, donor1 | 11506-119G3 |
1396.14 | 0.00 | 14.99 |
Fibroblast - Lymphatic, donor2 | 11586-120G2 |
1170.65 | 0.00 | 13.99 |
Fibroblast - Lymphatic, donor3 | 11667-122G2 |
983.48 | 0.00 | 6.44 |
Fibroblast - Mammary, donor1 | 11540-120B1 |
740.89 | 0.00 | 34.51 |
Fibroblast - Mammary, donor2 | 11620-122A9 |
1346.05 | 0.00 | 51.92 |
Fibroblast - Mammary, donor3 | 11701-123A9 |
1322.29 | 0.00 | 5.96 |
Fibroblast - Periodontal Ligament, donor1 | 11238-116D5 |
949.50 | 0.00 | 11.83 |
Fibroblast - Periodontal Ligament, donor2 | 11319-117D5 |
835.92 | 0.00 | 10.01 |
Fibroblast - Periodontal Ligament, donor3 | 11395-118C9 |
469.69 | 0.31 | 6.43 |
Fibroblast - Periodontal Ligament, donor4 (PL29) | 11223-116B8 |
574.34 | 0.00 | 16.79 |
Fibroblast - Periodontal Ligament, donor5 (PL30) | 11304-117B8 |
803.49 | 0.00 | 8.37 |
Fibroblast - Periodontal Ligament, donor6 (PLH3) | 11380-118B3 |
539.51 | 0.00 | 4.52 |
Fibroblast - Pulmonary Artery, donor1 | 11250-116E8 |
903.71 | 0.11 | 15.25 |
Fibroblast - Villous Mesenchymal, donor1 | 11535-120A5 |
789.19 | 0.00 | 20.73 |
Fibroblast - Villous Mesenchymal, donor2 | 11615-122A4 |
1524.84 | 0.00 | 27.40 |
Fibroblast - Villous Mesenchymal, donor3 | 11696-123A4 |
1364.79 | 0.00 | 18.98 |
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction) | 14329-155E9 |
241.51 | 0.00 | 7.54 |
Fibroblast - skin dystrophia myotonica, donor1 | 11556-120C8 |
565.36 | 0.00 | 6.75 |
Fibroblast - skin dystrophia myotonica, donor2 | 11557-120C9 |
693.94 | 0.00 | 12.02 |
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction) | 14308-155C6 |
309.28 | 0.00 | 14.44 |
Fibroblast - skin dystrophia myotonica, donor3 | 11560-120D3 |
836.95 | 0.11 | 10.90 |
Fibroblast - skin normal, donor1 (nuclear fraction) | 14323-155E3 |
247.25 | 0.00 | 4.56 |
Fibroblast - skin normal, donor1 | 11553-120C5 |
547.20 | 0.00 | 10.83 |
Fibroblast - skin normal, donor2 (nuclear fraction) | 14302-155B9 |
226.77 | 0.00 | 4.81 |
Fibroblast - skin normal, donor2 | 11561-120D4 |
766.83 | 0.00 | 11.65 |
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction) | 14326-155E6 |
320.07 | 0.00 | 9.67 |
Fibroblast - skin spinal muscular atrophy, donor1 | 11555-120C7 |
724.99 | 0.00 | 3.15 |
Fibroblast - skin spinal muscular atrophy, donor2 | 11558-120D1 |
988.27 | 0.00 | 6.33 |
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction) | 14305-155C3 |
179.98 | 0.00 | 12.15 |
Fibroblast - skin spinal muscular atrophy, donor3 | 11559-120D2 |
806.90 | 0.00 | 13.21 |
Fibroblast - skin walker warburg, donor1 | 11554-120C6 |
647.90 | 0.00 | 25.81 |
Fibroblast - skin, normal donor1 (cytoplasmic fraction) | 14322-155E2 |
798.06 | 0.47 | 20.70 |
Fibroblast - skin, normal donor2 (cytoplasmic fraction) | 14301-155B8 |
553.99 | 0.00 | 66.48 |
Fingernail (including nail plate, eponychium and hyponychium), donor2 | 10301-104H4 |
1424.08 | 0.00 | 19.17 |
Gingival epithelial cells, donor1 (GEA11) | 11221-116B6 |
673.32 | 0.00 | 5.37 |
Gingival epithelial cells, donor2 (GEA14) | 11302-117B6 |
670.90 | 0.00 | 7.55 |
Gingival epithelial cells, donor3 (GEA15) | 11379-118B2 |
763.22 | 0.00 | 6.90 |
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1 | 13523-145F4 |
2734.55 | 0.00 | 84.98 |
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2 | 13524-145F5 |
2396.60 | 0.00 | 107.20 |
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3 | 13525-145F6 |
3795.15 | 0.00 | 62.47 |
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1 | 13526-145F7 |
3222.50 | 0.00 | 14.06 |
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2 | 13527-145F8 |
1972.51 | 0.23 | 11.64 |
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3 | 13528-145F9 |
2780.56 | 0.00 | 36.26 |
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1 | 13529-145G1 |
3217.75 | 0.00 | 14.54 |
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2 | 13530-145G2 |
2191.38 | 0.00 | 11.42 |
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3 | 13531-145G3 |
3669.57 | 0.44 | 37.59 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0) | 12627-134E8 |
1272.89 | 0.00 | 31.23 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0) | 12725-135G7 |
999.92 | 0.12 | 22.90 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0) | 12823-136I6 |
1172.82 | 0.00 | 30.35 |
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1) | 12628-134E9 |
908.14 | 0.00 | 15.61 |
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1) | 12726-135G8 |
1018.13 | 0.14 | 19.93 |
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1) | 12824-136I7 |
904.09 | 0.00 | 14.23 |
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3) | 12629-134F1 |
916.59 | 0.00 | 12.55 |
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3) | 12727-135G9 |
794.23 | 0.00 | 12.33 |
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3) | 12825-136I8 |
757.37 | 0.00 | 9.62 |
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6) | 12630-134F2 |
1150.01 | 0.00 | 16.25 |
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6) | 12728-135H1 |
924.98 | 0.00 | 20.03 |
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6) | 12826-136I9 |
894.35 | 0.00 | 14.97 |
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9) | 12631-134F3 |
909.37 | 0.00 | 11.90 |
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9) | 12729-135H2 |
902.84 | 0.17 | 23.41 |
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9) | 12827-137A1 |
701.04 | 0.00 | 6.03 |
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12) | 12632-134F4 |
669.18 | 0.00 | 5.93 |
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12) | 12632-134F4 |
606.60 | 0.00 | 12.13 |
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12) | 12730-135H3 |
843.29 | 0.00 | 15.60 |
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12) | 12828-137A2 |
744.69 | 0.08 | 6.74 |
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12) | 12828-137A2 |
703.40 | 0.20 | 17.76 |
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15) | 12633-134F5 |
931.88 | 0.00 | 11.76 |
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15) | 12731-135H4 |
844.99 | 0.00 | 12.57 |
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15) | 12829-137A3 |
827.65 | 0.00 | 15.01 |
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18) | 12634-134F6 |
881.50 | 0.00 | 9.04 |
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18) | 12732-135H5 |
910.02 | 0.00 | 12.18 |
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18) | 12830-137A4 |
850.82 | 0.00 | 14.75 |
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21) | 12635-134F7 |
969.84 | 0.32 | 6.09 |
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21) | 12733-135H6 |
784.09 | 0.00 | 15.54 |
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21) | 12831-137A5 |
890.69 | 0.00 | 10.91 |
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24) | 12636-134F8 |
822.25 | 0.00 | 9.73 |
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24) | 12734-135H7 |
784.04 | 0.00 | 17.04 |
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24) | 12832-137A6 |
868.56 | 0.00 | 10.76 |
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27) | 12637-134F9 |
828.18 | 0.00 | 8.42 |
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27) | 12735-135H8 |
470.25 | 0.00 | 18.70 |
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27) | 12833-137A7 |
740.71 | 0.00 | 17.38 |
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30) | 12638-134G1 |
604.06 | 0.00 | 16.68 |
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30) | 12736-135H9 |
641.34 | 0.13 | 24.09 |
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30) | 12834-137A8 |
693.68 | 0.27 | 13.82 |
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34) | 12639-134G2 |
633.06 | 0.18 | 11.25 |
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34) | 12737-135I1 |
609.03 | 0.00 | 8.99 |
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34) | 12835-137A9 |
291.57 | 0.00 | 3.97 |
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41) | 12640-134G3 |
529.76 | 0.00 | 9.37 |
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41) | 12738-135I2 |
579.24 | 0.00 | 9.28 |
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41) | 12836-137B1 |
210.70 | 0.00 | 1.02 |
H9 Embryonic Stem cells, biol_rep1 (H9ES-1) | 12626-134E7 |
1546.10 | 0.00 | 26.87 |
H9 Embryonic Stem cells, biol_rep2 (H9ES-2) | 12724-135G6 |
1178.22 | 0.00 | 23.73 |
H9 Embryonic Stem cells, biol_rep3 (H9ES-3) | 12822-136I5 |
1410.39 | 0.00 | 38.87 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1) | 13364-143F7 |
2470.90 | 0.00 | 47.25 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2) | 13365-143F8 |
2543.00 | 0.57 | 42.10 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3) | 13366-143F9 |
1806.54 | 0.00 | 50.27 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1 | 13328-143B7 |
2645.56 | 0.00 | 94.04 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2 | 13340-143D1 |
2048.15 | 0.00 | 65.76 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3 | 13352-143E4 |
3398.26 | 0.00 | 33.69 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1 | 13329-143B8 |
1709.27 | 0.00 | 67.81 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2 | 13341-143D2 |
1993.56 | 0.00 | 59.56 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3 | 13353-143E5 |
1710.62 | 0.00 | 58.48 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1 | 13330-143B9 |
1546.17 | 0.00 | 39.99 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2 | 13342-143D3 |
1897.97 | 0.00 | 55.09 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3 | 13354-143E6 |
1717.89 | 0.00 | 47.07 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1 | 13331-143C1 |
1551.85 | 0.00 | 38.59 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2 | 13343-143D4 |
1820.96 | 0.32 | 51.21 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3 | 13355-143E7 |
1904.48 | 0.00 | 49.25 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1 | 13332-143C2 |
2699.97 | 0.00 | 79.35 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2 | 13344-143D5 |
2341.77 | 0.00 | 37.80 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3 | 13356-143E8 |
1901.99 | 0.00 | 36.70 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1 | 13333-143C3 |
2400.60 | 0.00 | 69.46 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2 | 13345-143D6 |
1923.58 | 0.00 | 60.47 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3 | 13357-143E9 |
1814.80 | 0.00 | 55.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1 | 13334-143C4 |
2418.24 | 0.00 | 136.98 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2 | 13346-143D7 |
1791.36 | 0.00 | 46.51 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3 | 13358-143F1 |
1979.94 | 0.00 | 38.14 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1 | 13335-143C5 |
2971.66 | 0.00 | 60.86 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2 | 13347-143D8 |
1927.50 | 0.00 | 28.12 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3 | 13359-143F2 |
1632.96 | 0.00 | 27.73 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1 | 13336-143C6 |
1997.77 | 0.00 | 29.82 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2 | 13348-143D9 |
2995.31 | 0.00 | 39.16 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3 | 13360-143F3 |
2176.20 | 0.00 | 22.93 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1 | 13337-143C7 |
2527.61 | 0.00 | 35.10 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2 | 13349-143E1 |
2275.37 | 0.00 | 34.70 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3 | 13361-143F4 |
2443.59 | 0.00 | 28.61 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1 | 13338-143C8 |
2694.95 | 0.00 | 40.13 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2 | 13350-143E2 |
2753.87 | 0.00 | 36.76 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3 | 13362-143F5 |
2361.19 | 0.00 | 16.68 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1 | 13339-143C9 |
1995.47 | 0.00 | 17.80 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2 | 13351-143E3 |
1422.45 | 0.00 | 30.44 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3 | 13363-143F6 |
2265.62 | 0.00 | 43.67 |
Hair Follicle Dermal Papilla Cells, donor1 | 11271-116H2 |
766.96 | 0.00 | 21.68 |
Hair Follicle Dermal Papilla Cells, donor2 | 11348-117G7 |
535.99 | 0.00 | 4.99 |
Hair Follicle Dermal Papilla Cells, donor3 | 11420-118F7 |
1194.17 | 1.12 | 12.37 |
Hair Follicle Outer Root Sheath Cells, donor1 | 11504-119G1 |
786.56 | 0.00 | 5.39 |
Hair Follicle Outer Root Sheath Cells, donor2 | 11584-120F9 |
1035.17 | 0.84 | 10.86 |
Hep-2 cells mock treated, biol_rep1 | 11898-125E8 |
1010.96 | 0.12 | 18.22 |
Hep-2 cells mock treated, biol_rep2 | 11899-125E9 |
809.74 | 0.34 | 31.90 |
Hep-2 cells mock treated, biol_rep3 | 11900-125F1 |
808.55 | 0.23 | 31.85 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep1 | 11890-125D9 |
1011.33 | 0.22 | 15.52 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep2 | 11891-125E1 |
820.96 | 0.00 | 30.09 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep3 | 11892-125E2 |
795.90 | 0.00 | 27.56 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1 | 11894-125E4 |
1130.55 | 0.25 | 17.06 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2 | 11895-125E5 |
856.72 | 0.00 | 27.79 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3 | 11896-125E6 |
824.64 | 0.00 | 31.40 |
Hepatic Sinusoidal Endothelial Cells, donor1 | 11521-119H9 |
1002.84 | 0.00 | 18.47 |
Hepatic Sinusoidal Endothelial Cells, donor2 | 11601-120H8 |
1149.93 | 0.00 | 27.70 |
Hepatic Sinusoidal Endothelial Cells, donor3 | 11682-122H8 |
1184.43 | 0.00 | 13.22 |
Hepatic Stellate Cells (lipocyte), donor1 | 11524-119I3 |
893.44 | 0.00 | 22.57 |
Hepatic Stellate Cells (lipocyte), donor2 | 11604-120I2 |
1356.40 | 0.73 | 20.34 |
Hepatic Stellate Cells (lipocyte), donor3 | 11685-122I2 |
994.66 | 0.17 | 40.56 |
Hepatocyte, donor1 | 11523-119I2 |
489.08 | 0.00 | 18.16 |
Hepatocyte, donor2 | 11603-120I1 |
541.90 | 0.00 | 15.08 |
Hepatocyte, donor3 | 11684-122I1 |
572.43 | 0.00 | 13.50 |
Hodgkin's lymphoma cell line:HD-Mar2 | 10435-106E3 |
1189.19 | 0.00 | 11.10 |
Intestinal epithelial cells (polarized), donor1 | 11246-116E4 |
714.16 | 0.17 | 7.69 |
Iris Pigment Epithelial Cells, donor1 | 11530-119I9 |
818.30 | 0.00 | 13.03 |
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1 | 13079-140B1 |
1190.77 | 0.00 | 35.02 |
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2 | 13145-140I4 |
787.69 | 0.00 | 13.35 |
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3 | 13211-141G7 |
1435.41 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1 | 13080-140B2 |
992.60 | 0.00 | 42.92 |
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2 | 13146-140I5 |
800.85 | 0.00 | 32.53 |
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3 | 13212-141G8 |
2670.36 | 0.00 | 11.87 |
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1 | 13081-140B3 |
927.77 | 0.00 | 61.51 |
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2 | 13147-140I6 |
827.31 | 0.00 | 36.57 |
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3 | 13213-141G9 |
1237.74 | 0.00 | 21.12 |
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1 | 13082-140B4 |
1183.79 | 1.67 | 46.68 |
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2 | 13148-140I7 |
722.48 | 0.00 | 36.31 |
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3 | 13214-141H1 |
984.66 | 0.00 | 25.15 |
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1 | 13083-140B5 |
1267.18 | 0.00 | 52.11 |
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2 | 13149-140I8 |
1079.09 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3 | 13215-141H2 |
1142.57 | 1.26 | 23.30 |
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1 | 13084-140B6 |
1285.24 | 0.00 | 55.68 |
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2 | 13150-140I9 |
746.37 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3 | 13216-141H3 |
1018.16 | 0.00 | 28.43 |
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1 | 13085-140B7 |
1106.02 | 0.00 | 35.42 |
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2 | 13151-141A1 |
1051.44 | 0.00 | 35.84 |
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3 | 13217-141H4 |
1088.68 | 0.00 | 22.00 |
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1 | 13086-140B8 |
935.34 | 0.00 | 12.17 |
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2 | 13152-141A2 |
905.46 | 0.00 | 28.74 |
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3 | 13218-141H5 |
1072.92 | 0.80 | 24.91 |
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1 | 13087-140B9 |
1083.01 | 0.00 | 36.93 |
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2 | 13153-141A3 |
452.42 | 0.00 | 30.16 |
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3 | 13219-141H6 |
1363.72 | 0.94 | 30.21 |
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1 | 13088-140C1 |
1129.19 | 0.91 | 52.60 |
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2 | 13154-141A4 |
722.38 | 0.00 | 29.48 |
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3 | 13220-141H7 |
1094.41 | 0.00 | 26.90 |
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1 | 13089-140C2 |
1232.35 | 2.54 | 45.74 |
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2 | 13155-141A5 |
870.81 | 0.00 | 115.01 |
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3 | 13221-141H8 |
810.49 | 0.00 | 23.59 |
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1 | 13090-140C3 |
1192.02 | 0.00 | 43.74 |
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2 | 13156-141A6 |
869.24 | 0.00 | 47.41 |
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3 | 13222-141H9 |
794.75 | 0.00 | 15.71 |
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1 | 13091-140C4 |
1051.91 | 0.00 | 29.86 |
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2 | 13157-141A7 |
625.46 | 0.00 | 41.70 |
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3 | 13223-141I1 |
1262.11 | 0.31 | 26.24 |
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1 | 13092-140C5 |
1115.07 | 1.76 | 43.90 |
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2 | 13158-141A8 |
990.08 | 0.00 | 50.29 |
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3 | 13224-141I2 |
920.69 | 0.70 | 29.90 |
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1 | 13093-140C6 |
1082.20 | 0.00 | 30.98 |
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2 | 13159-141A9 |
1115.25 | 0.00 | 81.05 |
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3 | 13225-141I3 |
836.18 | 0.00 | 14.82 |
K562 erythroblastic leukemia response to hemin, day02, biol_rep1 | 13094-140C7 |
1241.88 | 0.00 | 11.25 |
K562 erythroblastic leukemia response to hemin, day02, biol_rep2 | 13160-141B1 |
721.31 | 0.00 | 24.39 |
K562 erythroblastic leukemia response to hemin, day02, biol_rep3 | 13226-141I4 |
831.02 | 1.07 | 9.60 |
K562 erythroblastic leukemia response to hemin, day03, biol_rep1 | 13095-140C8 |
949.03 | 1.39 | 23.55 |
K562 erythroblastic leukemia response to hemin, day03, biol_rep2 | 13161-141B2 |
757.99 | 0.00 | 51.29 |
K562 erythroblastic leukemia response to hemin, day03, biol_rep3 | 13227-141I5 |
967.37 | 0.00 | 29.45 |
K562 erythroblastic leukemia response to hemin, day04, biol_rep1 | 13096-140C9 |
1191.98 | 3.03 | 27.23 |
K562 erythroblastic leukemia response to hemin, day04, biol_rep2 | 13162-141B3 |
707.79 | 0.00 | 12.42 |
K562 erythroblastic leukemia response to hemin, day04, biol_rep3 | 13228-141I6 |
1119.76 | 0.00 | 6.34 |
Keratinocyte - epidermal, donor1 | 11272-116H3 |
666.26 | 0.16 | 2.37 |
Keratinocyte - epidermal, donor2 | 11349-117G8 |
540.54 | 0.00 | 7.61 |
Keratinocyte - epidermal, donor3 | 11421-118F8 |
1193.23 | 0.19 | 19.78 |
Keratinocyte - oral, donor1 | 11251-116E9 |
1186.48 | 0.00 | 6.36 |
Keratocytes, donor1 | 11527-119I6 |
1239.17 | 0.00 | 15.82 |
Keratocytes, donor2 | 11607-120I5 |
1320.62 | 1.17 | 45.70 |
Keratocytes, donor3 | 11688-122I5 |
926.14 | 0.00 | 6.13 |
Krukenberg tumor cell line:HSKTC | 10687-109F3 |
789.05 | 0.00 | 26.37 |
Lens Epithelial Cells, donor1 | 11529-119I8 |
762.67 | 0.00 | 29.13 |
Lens Epithelial Cells, donor2 | 11609-120I7 |
827.05 | 0.00 | 3.58 |
Lens Epithelial Cells, donor3 | 11690-122I7 |
528.56 | 0.00 | 7.16 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1) | 12260-130A1 |
790.20 | 0.00 | 5.22 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1) | 12382-131E6 |
967.27 | 0.00 | 3.91 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 ) | 12504-133A2 |
797.92 | 0.16 | 5.19 |
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2) | 12261-130A2 |
751.19 | 0.00 | 20.97 |
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2) | 12383-131E7 |
922.17 | 0.00 | 4.10 |
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2) | 12505-133A3 |
914.37 | 0.00 | 8.19 |
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3) | 12262-130A3 |
709.98 | 0.00 | 11.49 |
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3) | 12384-131E8 |
1100.02 | 0.00 | 6.32 |
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3) | 12506-133A4 |
850.13 | 0.00 | 5.49 |
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4) | 12263-130A4 |
695.35 | 0.00 | 14.63 |
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4) | 12385-131E9 |
919.01 | 0.00 | 5.43 |
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4) | 12507-133A5 |
1041.46 | 0.00 | 7.59 |
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5) | 12264-130A5 |
798.94 | 0.35 | 13.59 |
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5) | 12386-131F1 |
935.25 | 0.00 | 5.49 |
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5) | 12508-133A6 |
881.50 | 0.14 | 4.94 |
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6) | 12265-130A6 |
744.34 | 0.00 | 11.39 |
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6) | 12387-131F2 |
1145.66 | 0.31 | 5.61 |
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6) | 12509-133A7 |
959.42 | 0.00 | 7.14 |
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7) | 12266-130A7 |
770.12 | 0.00 | 14.48 |
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7) | 12388-131F3 |
1107.94 | 0.00 | 6.15 |
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7) | 12510-133A8 |
1052.47 | 0.25 | 5.48 |
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8) | 12267-130A8 |
780.31 | 0.00 | 11.64 |
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8) | 12389-131F4 |
1021.71 | 0.00 | 7.81 |
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8) | 12511-133A9 |
906.00 | 0.00 | 7.42 |
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9) | 12268-130A9 |
832.05 | 0.00 | 14.00 |
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9) | 12390-131F5 |
933.25 | 0.21 | 5.03 |
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9) | 12512-133B1 |
889.75 | 0.00 | 5.86 |
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10) | 12269-130B1 |
837.83 | 0.00 | 20.64 |
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10) | 12391-131F6 |
932.84 | 0.00 | 8.28 |
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10) | 12513-133B2 |
912.81 | 0.00 | 7.00 |
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11) | 12270-130B2 |
742.86 | 0.48 | 13.08 |
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11) | 12392-131F7 |
990.05 | 0.00 | 5.29 |
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11) | 12514-133B3 |
896.11 | 0.00 | 5.08 |
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12) | 12271-130B3 |
734.50 | 0.00 | 12.96 |
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12) | 12393-131F8 |
973.50 | 0.25 | 4.69 |
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12) | 12515-133B4 |
921.89 | 0.00 | 7.56 |
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13) | 12272-130B4 |
729.80 | 0.00 | 5.47 |
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13) | 12394-131F9 |
968.07 | 0.30 | 6.09 |
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13) | 12516-133B5 |
849.31 | 0.14 | 7.14 |
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14) | 12273-130B5 |
791.12 | 0.00 | 15.64 |
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14) | 12395-131G1 |
1226.97 | 0.00 | 8.73 |
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14) | 12517-133B6 |
1049.42 | 0.16 | 7.00 |
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15) | 12274-130B6 |
872.70 | 0.00 | 10.74 |
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15) | 12396-131G2 |
1038.17 | 0.00 | 5.88 |
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15) | 12518-133B7 |
1076.83 | 0.24 | 6.12 |
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16) | 12275-130B7 |
722.21 | 0.25 | 5.32 |
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16) | 12397-131G3 |
1035.78 | 0.00 | 6.40 |
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16) | 12519-133B8 |
785.28 | 0.00 | 18.50 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1 | 13031-139E7 |
1948.77 | 2.27 | 2.27 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2 | 13097-140D1 |
1536.57 | 0.00 | 28.38 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3 | 13163-141B4 |
1147.48 | 0.00 | 40.82 |
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1 | 13032-139E8 |
1208.88 | 0.42 | 19.04 |
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2 | 13098-140D2 |
1207.61 | 0.00 | 30.95 |
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3 | 13164-141B5 |
1138.50 | 0.00 | 36.42 |
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1 | 13033-139E9 |
1004.77 | 0.00 | 16.49 |
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2 | 13099-140D3 |
1082.41 | 0.00 | 29.74 |
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3 | 13165-141B6 |
1109.25 | 0.00 | 8.82 |
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1 | 13034-139F1 |
1372.42 | 0.00 | 17.16 |
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2 | 13100-140D4 |
1361.78 | 0.00 | 21.61 |
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3 | 13166-141B7 |
1026.58 | 0.00 | 7.59 |
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1 | 13035-139F2 |
1244.78 | 0.00 | 13.87 |
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2 | 13101-140D5 |
1317.91 | 0.35 | 29.29 |
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3 | 13167-141B8 |
994.13 | 0.00 | 45.31 |
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1 | 13036-139F3 |
1282.12 | 0.00 | 11.72 |
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2 | 13102-140D6 |
1387.12 | 0.00 | 26.41 |
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3 | 13168-141B9 |
1623.79 | 0.19 | 17.01 |
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1 | 13037-139F4 |
1287.25 | 0.00 | 15.95 |
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2 | 13103-140D7 |
1187.26 | 0.00 | 25.28 |
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3 | 13169-141C1 |
1566.82 | 0.00 | 15.83 |
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1 | 13038-139F5 |
1436.06 | 0.00 | 16.26 |
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2 | 13104-140D8 |
1245.68 | 0.00 | 45.33 |
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3 | 13170-141C2 |
1533.68 | 0.00 | 22.06 |
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1 | 13039-139F6 |
1442.04 | 0.30 | 17.64 |
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2 | 13105-140D9 |
1346.63 | 0.00 | 35.41 |
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3 | 13171-141C3 |
1201.86 | 0.35 | 19.44 |
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1 | 13040-139F7 |
1485.45 | 0.00 | 15.12 |
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2 | 13106-140E1 |
1452.91 | 0.00 | 37.99 |
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3 | 13172-141C4 |
1485.89 | 0.38 | 16.12 |
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1 | 13041-139F8 |
1208.69 | 0.00 | 15.85 |
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2 | 13107-140E2 |
1408.74 | 0.00 | 32.82 |
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3 | 13173-141C5 |
1305.94 | 0.00 | 9.04 |
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1 | 13042-139F9 |
1602.18 | 0.00 | 17.24 |
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2 | 13108-140E3 |
1510.24 | 0.00 | 35.85 |
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3 | 13174-141C6 |
1326.96 | 0.00 | 13.01 |
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1 | 13043-139G1 |
1530.45 | 0.00 | 20.25 |
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2 | 13109-140E4 |
1479.68 | 0.00 | 42.81 |
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3 | 13175-141C7 |
1548.27 | 0.00 | 13.66 |
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1 | 13044-139G2 |
1533.01 | 0.60 | 16.29 |
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2 | 13110-140E5 |
1387.16 | 0.00 | 30.57 |
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3 | 13176-141C8 |
1504.11 | 0.00 | 14.44 |
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1 | 13045-139G3 |
1424.53 | 0.00 | 13.96 |
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2 | 13111-140E6 |
1326.52 | 0.67 | 28.95 |
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3 | 13177-141C9 |
1534.60 | 0.00 | 12.59 |
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1 | 13046-139G4 |
2267.71 | 0.00 | 11.63 |
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2 | 13112-140E7 |
1311.60 | 0.00 | 33.85 |
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3 | 13178-141D1 |
1514.97 | 0.00 | 13.20 |
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1 | 13048-139G6 |
1225.51 | 0.00 | 15.26 |
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2 | 13114-140E9 |
1316.11 | 0.77 | 22.23 |
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3 | 13180-141D3 |
1378.71 | 0.99 | 22.20 |
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1 | 13049-139G7 |
1105.59 | 0.00 | 9.41 |
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2 | 13115-140F1 |
1385.78 | 0.00 | 30.17 |
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3 | 13181-141D4 |
1270.31 | 0.00 | 20.28 |
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1 | 13050-139G8 |
1215.10 | 0.00 | 24.10 |
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2 | 13116-140F2 |
1381.01 | 0.00 | 29.84 |
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3 | 13182-141D5 |
1317.37 | 0.00 | 13.69 |
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1 | 13051-139G9 |
1341.90 | 0.00 | 11.22 |
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2 | 13117-140F3 |
1575.46 | 0.00 | 25.43 |
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3 | 13183-141D6 |
1253.63 | 0.00 | 13.13 |
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1 | 13052-139H1 |
1431.86 | 0.00 | 22.36 |
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2 | 13118-140F4 |
1500.26 | 0.00 | 20.76 |
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3 | 13184-141D7 |
1712.19 | 0.39 | 19.67 |
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1 | 13053-139H2 |
1488.18 | 0.00 | 17.22 |
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2 | 13119-140F5 |
1438.01 | 0.00 | 29.80 |
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3 | 13185-141D8 |
1433.95 | 0.80 | 14.71 |
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1 | 13054-139H3 |
1423.66 | 0.00 | 12.76 |
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2 | 13120-140F6 |
1571.55 | 0.00 | 31.13 |
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3 | 13186-141D9 |
1565.56 | 0.00 | 16.34 |
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1 | 13055-139H4 |
1468.69 | 0.52 | 17.56 |
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2 | 13121-140F7 |
1467.50 | 0.60 | 27.21 |
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3 | 13187-141E1 |
1488.80 | 0.00 | 17.43 |
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1 | 13056-139H5 |
1219.71 | 0.53 | 19.72 |
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2 | 13122-140F8 |
1230.94 | 0.00 | 26.43 |
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3 | 13188-141E2 |
1251.13 | 0.51 | 17.48 |
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1 | 13057-139H6 |
1371.56 | 0.00 | 11.32 |
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2 | 13123-140F9 |
1342.67 | 0.00 | 21.56 |
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3 | 13189-141E3 |
1285.52 | 0.00 | 14.14 |
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1 | 13058-139H7 |
1215.28 | 0.00 | 15.66 |
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2 | 13124-140G1 |
1454.32 | 0.00 | 20.04 |
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3 | 13190-141E4 |
1410.64 | 0.93 | 23.70 |
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1 | 13059-139H8 |
1348.80 | 0.00 | 20.74 |
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2 | 13125-140G2 |
1731.71 | 0.00 | 23.52 |
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3 | 13191-141E5 |
1245.42 | 0.00 | 16.97 |
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1 | 13060-139H9 |
1196.76 | 0.00 | 17.44 |
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2 | 13126-140G3 |
1289.21 | 0.00 | 31.12 |
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3 | 13192-141E6 |
1372.82 | 0.00 | 17.67 |
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1 | 13061-139I1 |
1240.84 | 0.00 | 13.04 |
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2 | 13127-140G4 |
1614.72 | 0.00 | 31.19 |
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3 | 13193-141E7 |
1206.27 | 0.45 | 20.05 |
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1 | 13062-139I2 |
1291.46 | 0.26 | 10.92 |
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2 | 13128-140G5 |
1770.50 | 0.66 | 24.53 |
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3 | 13194-141E8 |
2246.98 | 0.00 | 12.47 |
Macrophage - monocyte derived, donor1 | 11232-116C8 |
299.48 | 0.00 | 2.05 |
Macrophage - monocyte derived, donor2 | 11313-117C8 |
232.14 | 0.00 | 5.32 |
Macrophage - monocyte derived, donor3 | 11389-118C3 |
362.96 | 0.00 | 8.26 |
Mallassez-derived cells, donor1 (MZH3) | 12142-128E9 |
1110.90 | 0.00 | 17.52 |
Mallassez-derived cells, donor2 | 11929-125I3 |
572.65 | 0.00 | 16.16 |
Mallassez-derived cells, donor3 | 11930-125I4 |
911.34 | 0.00 | 23.35 |
Mammary Epithelial Cell, donor1 | 11273-116H4 |
1059.01 | 0.00 | 6.38 |
Mammary Epithelial Cell, donor2 | 11350-117G9 |
864.02 | 0.00 | 22.01 |
Mammary Epithelial Cell, donor3 | 11422-118F9 |
969.02 | 0.00 | 16.96 |
Mast cell - stimulated, donor1 | 11487-119E2 |
362.70 | 0.00 | 4.07 |
Mast cell, donor1 | 11563-120D6 |
453.87 | 0.00 | 2.70 |
Mast cell, donor2 | 11565-120D8 |
871.91 | 0.00 | 3.27 |
Mast cell, donor3 | 11566-120D9 |
967.14 | 0.00 | 1.80 |
Mast cell, donor4 | 11567-120E1 |
848.51 | 0.00 | 4.25 |
Mast cell, expanded and stimulated, donor5 | 11940-126A5 |
483.71 | 0.00 | 5.66 |
Mast cell, expanded and stimulated, donor8 | 11942-126A7 |
757.04 | 0.00 | 1.17 |
Mast cell, expanded, donor5 | 11939-126A4 |
504.78 | 0.00 | 2.41 |
Mast cell, expanded, donor8 | 11941-126A6 |
582.27 | 0.00 | 1.51 |
Melanocyte - dark, donor1 | 11502-119F8 |
794.69 | 0.00 | 9.25 |
Melanocyte - dark, donor2 | 11582-120F7 |
848.25 | 0.35 | 22.84 |
Melanocyte - dark, donor3 | 11663-122F7 |
686.23 | 0.00 | 13.26 |
Melanocyte - light, donor1 | 11274-116H5 |
337.33 | 0.00 | 5.41 |
Melanocyte - light, donor2 | 11351-117H1 |
400.61 | 0.68 | 8.19 |
Melanocyte - light, donor3 | 11423-118G1 |
560.23 | 0.00 | 5.20 |
Melanocyte, donor1 (MC+1) | 12641-134G4 |
702.22 | 0.00 | 26.14 |
Melanocyte, donor2 (MC+2) | 12739-135I3 |
929.46 | 0.00 | 7.53 |
Melanocyte, donor3 (MC+3) | 12837-137B2 |
556.07 | 0.00 | 11.52 |
Meningeal Cells, donor1 | 11493-119E8 |
1089.62 | 0.12 | 22.58 |
Meningeal Cells, donor2 | 11573-120E7 |
1406.71 | 0.00 | 35.21 |
Meningeal Cells, donor3 | 11654-122E7 |
813.79 | 0.16 | 12.47 |
Mesenchymal Stem Cells - Vertebral, donor1 | 11219-116B4 |
1170.00 | 0.00 | 12.55 |
Mesenchymal Stem Cells - Wharton's Jelly, donor1 | 11548-120B9 |
486.05 | 0.00 | 3.02 |
Mesenchymal Stem Cells - adipose, donor1 | 11537-120A7 |
1124.92 | 0.00 | 1.31 |
Mesenchymal Stem Cells - adipose, donor2 | 11617-122A6 |
1754.24 | 0.00 | 41.86 |
Mesenchymal Stem Cells - adipose, donor3 | 11698-123A6 |
1486.16 | 0.00 | 29.42 |
Mesenchymal Stem Cells - amniotic membrane, donor1 | 11547-120B8 |
427.77 | 0.00 | 6.14 |
Mesenchymal Stem Cells - amniotic membrane, donor2 | 11627-122B7 |
587.59 | 0.00 | 17.09 |
Mesenchymal Stem Cells - bone marrow, donor1 | 11536-120A6 |
1044.27 | 0.22 | 41.09 |
Mesenchymal Stem Cells - bone marrow, donor2 | 11616-122A5 |
1514.51 | 0.00 | 42.37 |
Mesenchymal Stem Cells - bone marrow, donor3 | 11697-123A5 |
1506.29 | 0.41 | 31.10 |
Mesenchymal Stem Cells - bone marrow, donor4 | 11464-119B6 |
988.53 | 0.14 | 4.02 |
Mesenchymal Stem Cells - hepatic, donor1 | 11538-120A8 |
935.26 | 0.00 | 16.36 |
Mesenchymal Stem Cells - hepatic, donor2 | 11618-122A7 |
934.84 | 0.13 | 2.76 |
Mesenchymal Stem Cells - umbilical, donor1 | 11539-120A9 |
1100.61 | 0.30 | 8.61 |
Mesenchymal Stem Cells - umbilical, donor2 | 11619-122A8 |
1527.45 | 0.00 | 9.34 |
Mesenchymal Stem Cells - umbilical, donor3 | 11700-123A8 |
1620.21 | 0.00 | 17.93 |
Mesenchymal stem cells - adipose, donor0 | 11217-116B2 |
1298.33 | 0.00 | 18.79 |
Mesenchymal stem cells - hepatic, donor0 | 11218-116B3 |
1005.09 | 0.31 | 4.07 |
Mesenchymal stem cells - umbilical, donor0 | 11214-116A8 |
1522.50 | 0.00 | 74.02 |
Mesothelial Cells, donor1 | 11247-116E5 |
433.03 | 0.00 | 2.92 |
Mesothelial Cells, donor2 | 12156-128G5 |
616.07 | 0.00 | 4.00 |
Mesothelial Cells, donor3 | 11402-118D7 |
379.24 | 0.00 | 5.78 |
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1) | 12698-135D7 |
264.66 | 0.00 | 2.70 |
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2) | 12796-136F6 |
417.19 | 0.00 | 7.39 |
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3) | 12894-137H5 |
361.60 | 0.00 | 6.48 |
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1) | 12699-135D8 |
459.79 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2) | 12797-136F7 |
380.92 | 0.00 | 10.54 |
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3) | 12895-137H6 |
312.81 | 0.00 | 5.19 |
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1) | 12700-135D9 |
402.99 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2) | 12798-136F8 |
376.89 | 0.00 | 8.51 |
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3) | 12896-137H7 |
338.40 | 0.00 | 3.72 |
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1) | 12701-135E1 |
408.79 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2) | 12799-136F9 |
357.25 | 0.00 | 7.93 |
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3) | 12897-137H8 |
325.88 | 0.00 | 2.38 |
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1) | 12702-135E2 |
393.37 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2) | 12800-136G1 |
412.38 | 0.00 | 6.19 |
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3) | 12898-137H9 |
456.68 | 0.00 | 5.32 |
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1) | 12703-135E3 |
271.08 | 0.00 | 1.32 |
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2) | 12801-136G2 |
382.00 | 0.00 | 4.24 |
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3) | 12899-137I1 |
253.23 | 0.00 | 0.92 |
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1) | 12704-135E4 |
0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2) | 12802-136G3 |
264.97 | 0.00 | 4.47 |
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3) | 12900-137I2 |
271.62 | 0.00 | 6.71 |
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1) | 12705-135E5 |
678.99 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2) | 12803-136G4 |
399.19 | 0.00 | 6.52 |
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3) | 12901-137I3 |
264.76 | 0.00 | 3.80 |
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1) | 12706-135E6 |
273.68 | 0.00 | 4.42 |
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2) | 12804-136G5 |
241.76 | 0.23 | 13.81 |
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3) | 12902-137I4 |
259.56 | 0.00 | 3.58 |
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1) | 12707-135E7 |
236.64 | 0.00 | 7.75 |
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2) | 12805-136G6 |
259.38 | 0.21 | 9.44 |
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3) | 12903-137I5 |
223.40 | 0.00 | 4.00 |
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1) | 12708-135E8 |
206.37 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2) | 12806-136G7 |
203.69 | 0.00 | 8.32 |
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3) | 12904-137I6 |
207.35 | 0.00 | 3.04 |
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1) | 12709-135E9 |
366.20 | 0.00 | 3.31 |
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2) | 12807-136G8 |
209.55 | 0.00 | 8.15 |
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3) | 12905-137I7 |
258.50 | 0.00 | 3.82 |
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1) | 12710-135F1 |
270.40 | 0.00 | 2.18 |
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2) | 12808-136G9 |
326.30 | 0.00 | 8.65 |
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3) | 12906-137I8 |
285.76 | 0.00 | 5.20 |
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1) | 12711-135F2 |
185.11 | 0.00 | 4.11 |
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2) | 12809-136H1 |
343.40 | 0.00 | 11.51 |
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3) | 12907-137I9 |
458.10 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1) | 12712-135F3 |
146.77 | 0.00 | 4.08 |
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2) | 12810-136H2 |
289.47 | 0.00 | 13.14 |
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3) | 12908-138A1 |
169.96 | 0.00 | 4.41 |
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1) | 12713-135F4 |
181.87 | 0.00 | 5.12 |
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2) | 12811-136H3 |
268.50 | 0.00 | 12.40 |
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3) | 12909-138A2 |
172.58 | 0.00 | 12.53 |
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1) | 12714-135F5 |
214.36 | 0.00 | 11.05 |
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2) | 12812-136H4 |
227.35 | 0.00 | 10.26 |
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3) | 12910-138A3 |
168.48 | 0.00 | 8.31 |
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1) | 12715-135F6 |
174.71 | 0.00 | 5.33 |
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2) | 12813-136H5 |
261.47 | 0.00 | 10.38 |
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3) | 12911-138A4 |
180.38 | 0.00 | 9.56 |
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1) | 12716-135F7 |
156.76 | 0.00 | 6.99 |
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2) | 12814-136H6 |
171.04 | 0.00 | 5.13 |
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3) | 12912-138A5 |
197.84 | 0.00 | 12.10 |
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1) | 12717-135F8 |
173.25 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2) | 12815-136H7 |
206.88 | 0.00 | 9.24 |
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3) | 12913-138A6 |
226.51 | 0.00 | 9.11 |
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1) | 12718-135F9 |
178.67 | 0.00 | 6.08 |
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2) | 12816-136H8 |
204.21 | 0.00 | 10.37 |
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3) | 12914-138A7 |
192.18 | 0.00 | 13.73 |
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1) | 12719-135G1 |
188.02 | 0.00 | 3.18 |
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2) | 12817-136H9 |
188.96 | 0.00 | 4.27 |
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3) | 12915-138A8 |
241.26 | 0.00 | 5.99 |
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1) | 12720-135G2 |
158.20 | 0.00 | 4.66 |
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2) | 12818-136I1 |
243.34 | 0.00 | 6.05 |
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3) | 12916-138A9 |
206.54 | 0.00 | 11.06 |
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1) | 12721-135G3 |
214.63 | 0.00 | 2.65 |
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2) | 12819-136I2 |
193.19 | 0.00 | 10.23 |
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3) | 12917-138B1 |
249.00 | 0.00 | 8.36 |
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1) | 12722-135G4 |
181.16 | 0.00 | 1.30 |
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2) | 12820-136I3 |
186.41 | 0.00 | 5.88 |
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3) | 12918-138B2 |
260.36 | 0.00 | 8.65 |
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1) | 12723-135G5 |
212.25 | 0.00 | 2.06 |
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2) | 12821-136I4 |
171.82 | 0.00 | 3.87 |
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h) | 13304-142I1 |
715.71 | 0.00 | 30.14 |
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h) | 13316-143A4 |
700.42 | 0.00 | 10.69 |
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h) | 13322-143B1 |
501.07 | 0.00 | 8.87 |
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h) | 13310-142I7 |
568.05 | 0.00 | 17.88 |
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h) | 13309-142I6 |
527.82 | 0.00 | 6.72 |
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h) | 13321-143A9 |
647.27 | 0.00 | 12.11 |
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h) | 13327-143B6 |
634.27 | 0.00 | 11.27 |
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h) | 13315-143A3 |
423.48 | 0.00 | 12.78 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h) | 13305-142I2 |
318.72 | 0.00 | 6.22 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h) | 13317-143A5 |
522.34 | 0.00 | 11.79 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h) | 13323-143B2 |
445.94 | 0.00 | 8.06 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h) | 13311-142I8 |
412.23 | 0.00 | 4.67 |
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h) | 13306-142I3 |
598.57 | 0.00 | 11.22 |
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h) | 13318-143A6 |
571.86 | 0.00 | 3.86 |
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h) | 13324-143B3 |
670.60 | 0.00 | 7.07 |
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h) | 13312-142I9 |
466.75 | 0.00 | 12.65 |
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h) | 13307-142I4 |
776.31 | 0.00 | 16.34 |
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h) | 13319-143A7 |
1190.84 | 0.00 | 10.81 |
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h) | 13325-143B4 |
1037.40 | 0.00 | 15.39 |
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h) | 13313-143A1 |
708.39 | 0.00 | 7.55 |
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h) | 13308-142I5 |
622.41 | 0.00 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h) | 13320-143A8 |
861.29 | 0.00 | 9.79 |
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h) | 13326-143B5 |
370.69 | 0.00 | 4.75 |
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h) | 13314-143A2 |
627.45 | 0.00 | 0.00 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1 | 11549-120C1 |
531.70 | 0.00 | 19.39 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2 | 11629-122B9 |
544.56 | 0.00 | 10.97 |
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1 | 13496-145C4 |
448.55 | 0.00 | 16.69 |
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2 | 13505-145D4 |
591.83 | 0.00 | 7.10 |
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3 | 13514-145E4 |
1460.67 | 0.00 | 34.23 |
Myoblast differentiation to myotubes, day00, control donor1 | 13469-144I4 |
1279.87 | 0.00 | 60.64 |
Myoblast differentiation to myotubes, day00, control donor2 | 13478-145A4 |
362.41 | 0.00 | 6.80 |
Myoblast differentiation to myotubes, day00, control donor3 | 13487-145B4 |
242.57 | 0.00 | 12.86 |
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1 | 13497-145C5 |
402.63 | 0.00 | 5.86 |
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2 | 13506-145D5 |
865.60 | 0.00 | 14.41 |
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3 | 13515-145E5 |
404.26 | 0.00 | 5.94 |
Myoblast differentiation to myotubes, day01, control donor1 | 13470-144I5 |
569.53 | 0.00 | 9.25 |
Myoblast differentiation to myotubes, day01, control donor2 | 13479-145A5 |
356.31 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day01, control donor3 | 13488-145B5 |
537.06 | 0.00 | 5.46 |
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1 | 13498-145C6 |
807.68 | 0.27 | 6.23 |
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2 | 13507-145D6 |
487.82 | 0.23 | 5.44 |
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3 | 13516-145E6 |
486.80 | 0.00 | 3.92 |
Myoblast differentiation to myotubes, day02, control donor1 | 13471-144I6 |
591.42 | 0.00 | 9.84 |
Myoblast differentiation to myotubes, day02, control donor2 | 13480-145A6 |
472.62 | 0.00 | 4.24 |
Myoblast differentiation to myotubes, day02, control donor3 | 13489-145B6 |
381.79 | 0.00 | 4.80 |
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1 | 13499-145C7 |
920.54 | 0.33 | 10.17 |
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2 | 13508-145D7 |
419.24 | 0.00 | 5.20 |
Myoblast differentiation to myotubes, day03, control donor1 | 13472-144I7 |
515.39 | 0.00 | 6.17 |
Myoblast differentiation to myotubes, day03, control donor2 | 13481-145A7 |
558.37 | 0.00 | 2.81 |
Myoblast differentiation to myotubes, day03, control donor3 | 13490-145B7 |
568.66 | 0.00 | 4.14 |
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1 | 13500-145C8 |
604.77 | 0.32 | 6.75 |
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2 | 13509-145D8 |
983.62 | 0.34 | 13.11 |
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3 | 13518-145E8 |
268.02 | 0.00 | 10.11 |
Myoblast differentiation to myotubes, day04, control donor1 | 13473-144I8 |
563.87 | 0.00 | 5.79 |
Myoblast differentiation to myotubes, day04, control donor2 | 13482-145A8 |
616.46 | 0.85 | 5.93 |
Myoblast differentiation to myotubes, day04, control donor3 | 13491-145B8 |
694.73 | 0.00 | 6.41 |
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1 | 13501-145C9 |
685.94 | 0.00 | 8.58 |
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2 | 13510-145D9 |
361.11 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3 | 13519-145E9 |
739.75 | 0.00 | 5.00 |
Myoblast differentiation to myotubes, day06, control donor1 | 13474-144I9 |
744.37 | 0.00 | 4.51 |
Myoblast differentiation to myotubes, day06, control donor2 | 13483-145A9 |
634.88 | 0.40 | 8.33 |
Myoblast differentiation to myotubes, day06, control donor3 | 13492-145B9 |
445.75 | 0.00 | 9.29 |
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1 | 13502-145D1 |
1009.12 | 0.00 | 10.59 |
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2 | 13511-145E1 |
465.36 | 0.00 | 8.47 |
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3 | 13520-145F1 |
468.47 | 0.00 | 3.49 |
Myoblast differentiation to myotubes, day08, control donor1 | 13475-145A1 |
634.56 | 0.45 | 10.40 |
Myoblast differentiation to myotubes, day08, control donor2 | 13484-145B1 |
432.14 | 0.00 | 8.82 |
Myoblast differentiation to myotubes, day08, control donor3 | 13493-145C1 |
476.69 | 0.00 | 5.32 |
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1 | 13503-145D2 |
585.33 | 0.00 | 1.98 |
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2 | 13512-145E2 |
409.62 | 0.00 | 6.13 |
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3 | 13521-145F2 |
790.90 | 0.00 | 5.44 |
Myoblast differentiation to myotubes, day10, control donor1 | 13476-145A2 |
495.31 | 0.00 | 10.39 |
Myoblast differentiation to myotubes, day10, control donor2 | 13485-145B2 |
395.07 | 0.68 | 8.13 |
Myoblast differentiation to myotubes, day10, control donor3 | 13494-145C2 |
204.38 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1 | 13504-145D3 |
765.76 | 0.00 | 4.88 |
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2 | 13513-145E3 |
481.23 | 0.00 | 3.15 |
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3 | 13522-145F3 |
514.51 | 0.00 | 4.24 |
Myoblast differentiation to myotubes, day12, control donor1 | 13477-145A3 |
362.34 | 0.00 | 4.75 |
Myoblast differentiation to myotubes, day12, control donor2 | 13486-145B3 |
581.56 | 0.00 | 6.80 |
Myoblast differentiation to myotubes, day12, control donor3 | 13495-145C3 |
318.65 | 0.00 | 5.06 |
Myoblast, donor1 | 11241-116D8 |
722.89 | 0.12 | 7.83 |
Myoblast, donor2 | 11322-117D8 |
887.02 | 0.19 | 5.37 |
Myoblast, donor3 | 11398-118D3 |
674.00 | 0.34 | 6.39 |
NK T cell leukemia cell line:KHYG-1 | 10777-110G3 |
1285.52 | 0.44 | 15.76 |
Natural Killer Cells, donor1 | 11230-116C6 |
1087.07 | 0.31 | 3.08 |
Natural Killer Cells, donor2 | 11311-117C6 |
1439.33 | 0.00 | 3.92 |
Natural Killer Cells, donor3 | 11387-118C1 |
1134.32 | 0.00 | 5.34 |
Neural stem cells, donor1 | 11275-116H6 |
574.53 | 0.00 | 7.62 |
Neural stem cells, donor2 | 11352-117H2 |
387.05 | 0.00 | 9.63 |
Neurons, donor1 | 11494-119E9 |
890.97 | 0.00 | 28.45 |
Neurons, donor2 | 11574-120E8 |
662.69 | 0.00 | 7.27 |
Neurons, donor3 | 11655-122E8 |
1199.54 | 0.00 | 21.38 |
Neutrophils, donor1 | 11233-116C9 |
34.34 | 0.00 | 0.93 |
Neutrophils, donor2 | 11314-117C9 |
28.99 | 0.00 | 0.00 |
Neutrophils, donor3 | 11390-118C4 |
43.98 | 0.00 | 0.00 |
Nucleus Pulposus Cell, donor1 | 11252-116F1 |
681.42 | 0.24 | 2.14 |
Nucleus Pulposus Cell, donor2 | 11409-118E5 |
1321.95 | 0.00 | 0.65 |
Nucleus Pulposus Cell, donor3 | 11462-119B4 |
1390.63 | 0.00 | 11.23 |
Olfactory epithelial cells, donor1 | 11933-125I7 |
696.79 | 0.00 | 3.44 |
Olfactory epithelial cells, donor2 | 11934-125I8 |
869.05 | 0.14 | 4.92 |
Olfactory epithelial cells, donor3 | 11935-125I9 |
784.43 | 0.00 | 5.33 |
Olfactory epithelial cells, donor4 | 11936-126A1 |
692.69 | 0.00 | 4.58 |
Oligodendrocyte - precursors, donor1 | 11496-119F2 |
804.03 | 0.60 | 9.03 |
Osteoblast - differentiated, donor1 | 11276-116H7 |
792.07 | 0.43 | 4.68 |
Osteoblast - differentiated, donor2 | 11353-117H3 |
1443.75 | 0.00 | 9.14 |
Osteoblast - differentiated, donor3 | 11425-118G3 |
2858.99 | 0.00 | 9.93 |
Osteoblast, donor1 | 11277-116H8 |
2227.79 | 0.39 | 16.81 |
Osteoblast, donor2 | 11354-117H4 |
596.27 | 0.00 | 27.39 |
Osteoblast, donor3 | 11426-118G4 |
1267.93 | 0.00 | 25.24 |
Pancreatic stromal cells, donor1 | 11249-116E7 |
712.46 | 0.08 | 5.14 |
Pericytes, donor1 | 11491-119E6 |
999.28 | 0.00 | 5.45 |
Pericytes, donor2 | 11571-120E5 |
1638.66 | 0.00 | 12.68 |
Pericytes, donor3 | 11652-122E5 |
1389.97 | 0.00 | 18.11 |
Perineurial Cells, donor1 | 11499-119F5 |
908.92 | 0.00 | 9.95 |
Perineurial Cells, donor2 | 11579-120F4 |
758.81 | 0.00 | 8.28 |
Peripheral Blood Mononuclear Cells, donor1 | 11231-116C7 |
963.23 | 0.00 | 1.91 |
Peripheral Blood Mononuclear Cells, donor2 | 11312-117C7 |
889.58 | 0.00 | 0.98 |
Peripheral Blood Mononuclear Cells, donor3 | 11388-118C2 |
856.86 | 0.00 | 3.88 |
Placental Epithelial Cells, donor1 | 11278-116H9 |
1170.96 | 0.00 | 14.83 |
Placental Epithelial Cells, donor2 | 11355-117H5 |
1022.39 | 0.00 | 13.31 |
Placental Epithelial Cells, donor3 | 11427-118G5 |
1308.13 | 0.00 | 11.39 |
Preadipocyte - breast donor2 (cytoplasmic fraction) | 14319-155D8 |
442.08 | 0.00 | 13.92 |
Preadipocyte - breast, donor1 | 11467-119B9 |
506.86 | 0.00 | 2.44 |
Preadipocyte - breast, donor2 (nuclear fraction) | 14320-155D9 |
116.04 | 0.00 | 2.35 |
Preadipocyte - breast, donor2 | 11328-117E5 |
729.26 | 0.00 | 7.66 |
Preadipocyte - omental, donor1 | 11468-119C1 |
480.26 | 0.00 | 2.88 |
Preadipocyte - omental, donor2 | 11329-117E6 |
450.44 | 0.00 | 4.36 |
Preadipocyte - omental, donor3 | 11403-118D8 |
527.01 | 0.00 | 8.59 |
Preadipocyte - perirenal, donor1 | 11469-119C2 |
928.16 | 0.00 | 21.65 |
Preadipocyte - subcutaneous, donor1 | 11279-116I1 |
742.92 | 0.00 | 11.36 |
Preadipocyte - subcutaneous, donor2 | 11356-117H6 |
1187.66 | 0.00 | 18.59 |
Preadipocyte - subcutaneous, donor3 | 11428-118G6 |
1168.15 | 0.00 | 23.67 |
Preadipocyte - visceral, donor1 | 11280-116I2 |
830.04 | 0.19 | 11.55 |
Preadipocyte - visceral, donor2 | 11357-117H7 |
816.36 | 0.00 | 6.44 |
Preadipocyte - visceral, donor3 | 11429-118G7 |
1217.11 | 0.00 | 24.56 |
Prostate Epithelial Cells (polarized), donor1 | 11253-116F2 |
1052.80 | 0.00 | 8.45 |
Prostate Epithelial Cells, donor2 | 11331-117E8 |
617.89 | 0.41 | 7.45 |
Prostate Epithelial Cells, donor3 | 11404-118D9 |
960.63 | 0.06 | 4.90 |
Prostate Stromal Cells, donor1 | 11254-116F3 |
794.91 | 0.00 | 7.40 |
Prostate Stromal Cells, donor2 | 11332-117E9 |
1115.60 | 0.36 | 8.07 |
Prostate Stromal Cells, donor3 | 11405-118E1 |
764.03 | 0.42 | 7.30 |
Renal Cortical Epithelial Cells, donor1 | 11516-119H4 |
948.95 | 0.73 | 18.61 |
Renal Cortical Epithelial Cells, donor2 | 11596-120H3 |
686.19 | 0.07 | 3.74 |
Renal Epithelial Cells, donor1 | 11517-119H5 |
1238.15 | 0.00 | 33.48 |
Renal Epithelial Cells, donor2 | 11597-120H4 |
1357.20 | 0.00 | 44.81 |
Renal Epithelial Cells, donor3 | 11678-122H4 |
739.25 | 0.00 | 4.45 |
Renal Glomerular Endothelial Cells, donor1 | 11514-119H2 |
1226.90 | 0.00 | 34.04 |
Renal Glomerular Endothelial Cells, donor2 | 11594-120H1 |
1214.50 | 0.13 | 30.86 |
Renal Glomerular Endothelial Cells, donor3 | 11675-122H1 |
826.10 | 0.00 | 33.75 |
Renal Glomerular Endothelial Cells, donor4 | 11783-124B1 |
1073.36 | 0.00 | 22.63 |
Renal Mesangial Cells, donor1 | 11518-119H6 |
930.53 | 0.22 | 25.75 |
Renal Mesangial Cells, donor2 | 11598-120H5 |
1234.53 | 0.00 | 28.84 |
Renal Mesangial Cells, donor3 | 11679-122H5 |
1342.39 | 0.00 | 14.98 |
Renal Proximal Tubular Epithelial Cell, donor1 | 11515-119H3 |
958.00 | 0.27 | 35.70 |
Renal Proximal Tubular Epithelial Cell, donor2 | 11595-120H2 |
977.48 | 0.00 | 23.19 |
Renal Proximal Tubular Epithelial Cell, donor3 | 11676-122H2 |
1394.86 | 0.00 | 19.67 |
Retinal Pigment Epithelial Cells, donor0 | 11215-116A9 |
1051.65 | 0.26 | 12.96 |
Retinal Pigment Epithelial Cells, donor1 | 11528-119I7 |
952.22 | 0.00 | 15.92 |
Retinal Pigment Epithelial Cells, donor2 | 11608-120I6 |
1404.75 | 0.00 | 48.37 |
Retinal Pigment Epithelial Cells, donor3 | 11689-122I6 |
1034.49 | 0.00 | 4.01 |
SABiosciences XpressRef Human Universal Total RNA, pool1 | 10002-101A5 |
612.19 | 0.00 | 2.14 |
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17) | 12697-135D6 |
1452.68 | 0.89 | 24.12 |
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17) | 12795-136F5 |
934.53 | 0.00 | 47.33 |
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17) | 12893-137H4 |
755.23 | 0.00 | 28.42 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0) | 12662-134I7 |
1669.00 | 0.13 | 28.22 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0) | 12760-136B6 |
1537.15 | 0.00 | 22.64 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0) | 12858-137D5 |
1482.80 | 0.11 | 19.74 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1) | 12663-134I8 |
1734.74 | 0.00 | 25.43 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1) | 12761-136B7 |
1648.18 | 0.12 | 25.52 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1) | 12859-137D6 |
1625.78 | 0.00 | 22.65 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2) | 12664-134I9 |
1399.62 | 0.14 | 58.73 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2) | 12762-136B8 |
1445.11 | 0.00 | 21.48 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2) | 12860-137D7 |
1539.07 | 0.00 | 20.25 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3) | 12665-135A1 |
1623.50 | 0.00 | 56.23 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3) | 12763-136B9 |
1557.67 | 0.00 | 24.57 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3) | 12861-137D8 |
1898.49 | 0.22 | 32.31 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4) | 12666-135A2 |
1149.54 | 0.00 | 76.28 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4) | 12764-136C1 |
1459.68 | 0.00 | 23.66 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4) | 12862-137D9 |
1368.53 | 0.00 | 18.79 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5) | 12667-135A3 |
1744.56 | 0.00 | 60.65 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5) | 12765-136C2 |
1363.55 | 0.19 | 24.24 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5) | 12863-137E1 |
1694.38 | 0.00 | 24.06 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6) | 12668-135A4 |
1696.73 | 0.00 | 44.53 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6) | 12766-136C3 |
1483.38 | 0.00 | 19.34 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6) | 12864-137E2 |
1556.20 | 0.00 | 25.29 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7) | 12669-135A5 |
1702.60 | 0.00 | 43.94 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7) | 12767-136C4 |
1462.14 | 0.12 | 23.67 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7) | 12865-137E3 |
1770.74 | 0.00 | 33.98 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8) | 12670-135A6 |
1552.28 | 0.00 | 78.55 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8) | 12768-136C5 |
1552.39 | 0.00 | 21.43 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8) | 12866-137E4 |
1856.74 | 0.23 | 27.83 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9) | 12671-135A7 |
1542.52 | 0.00 | 84.60 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9) | 12769-136C6 |
1722.78 | 0.00 | 24.78 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9) | 12867-137E5 |
1667.31 | 0.21 | 30.71 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10) | 12672-135A8 |
1659.29 | 0.00 | 58.14 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10) | 12770-136C7 |
1462.49 | 0.00 | 26.06 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10) | 12868-137E6 |
1502.64 | 0.00 | 23.71 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11) | 12673-135A9 |
1361.40 | 0.17 | 80.47 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11) | 12771-136C8 |
1520.24 | 0.00 | 23.46 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11) | 12869-137E7 |
1676.50 | 0.16 | 25.61 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12) | 12674-135B1 |
1228.29 | 0.00 | 71.92 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12) | 12772-136C9 |
1584.77 | 0.00 | 27.52 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12) | 12870-137E8 |
1221.34 | 0.00 | 39.72 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13) | 12675-135B2 |
1682.70 | 0.00 | 31.80 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13) | 12773-136D1 |
2005.06 | 0.00 | 29.29 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13) | 12871-137E9 |
1370.88 | 0.00 | 31.24 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14) | 12676-135B3 |
1827.73 | 0.00 | 36.54 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14) | 12774-136D2 |
1994.16 | 0.35 | 14.32 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14) | 12872-137F1 |
1583.90 | 0.00 | 26.29 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15) | 12677-135B4 |
2029.90 | 0.00 | 39.90 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15) | 12775-136D3 |
1103.72 | 0.00 | 11.94 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15) | 12873-137F2 |
1948.19 | 0.00 | 23.73 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16) | 12678-135B5 |
1895.50 | 0.00 | 68.72 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16) | 12776-136D4 |
1393.32 | 0.00 | 16.29 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16) | 12874-137F3 |
1096.92 | 0.30 | 22.17 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17) | 12679-135B6 |
1548.19 | 0.24 | 18.54 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17) | 12777-136D5 |
1520.15 | 0.43 | 17.08 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17) | 12875-137F4 |
1050.51 | 0.60 | 23.44 |
Schwann Cells, donor1 | 11498-119F4 |
2477.46 | 0.00 | 33.29 |
Schwann Cells, donor2 | 11578-120F3 |
918.65 | 0.00 | 17.01 |
Schwann Cells, donor3 | 11659-122F3 |
894.51 | 0.00 | 22.78 |
Sebocyte, donor1 | 11220-116B5 |
620.07 | 0.00 | 6.57 |
Sebocyte, donor2 | 11301-117B5 |
768.83 | 0.00 | 7.81 |
Sebocyte, donor3 | 11378-118B1 |
989.75 | 1.03 | 8.04 |
Sertoli Cells, donor1 | 11255-116F4 |
833.27 | 0.00 | 3.31 |
Sertoli Cells, donor2 | 11333-117F1 |
1262.49 | 0.00 | 2.82 |
Skeletal Muscle Cells, donor1 | 11281-116I3 |
1325.65 | 0.09 | 6.86 |
Skeletal Muscle Cells, donor2 | 11358-117H8 |
1189.80 | 0.72 | 5.78 |
Skeletal Muscle Cells, donor3 | 11430-118G8 |
1736.45 | 0.00 | 20.90 |
Skeletal Muscle Cells, donor4 | 11451-119A2 |
1650.90 | 0.00 | 31.73 |
Skeletal Muscle Cells, donor5 | 11455-119A6 |
1580.98 | 0.00 | 21.40 |
Skeletal Muscle Cells, donor6 | 11459-119B1 |
1661.99 | 0.00 | 33.09 |
Skeletal Muscle Satellite Cells, donor1 | 11240-116D7 |
1092.47 | 0.00 | 7.31 |
Skeletal Muscle Satellite Cells, donor2 | 11321-117D7 |
1192.73 | 0.00 | 7.99 |
Skeletal Muscle Satellite Cells, donor3 | 11397-118D2 |
1207.88 | 0.20 | 23.91 |
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1 | 11282-116I4 |
1058.96 | 0.08 | 6.40 |
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2 | 11359-117H9 |
1882.51 | 0.00 | 16.65 |
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3 | 11431-118G9 |
1351.77 | 0.14 | 19.40 |
Skin - palm, donor1 | 10286-104F7 |
1262.47 | 0.00 | 10.74 |
Small Airway Epithelial Cells donor2 (cytoplasmic fraction) | 14334-155F5 |
669.61 | 0.29 | 13.98 |
Small Airway Epithelial Cells donor2 (nuclear fraction) | 14335-155F6 |
144.77 | 0.82 | 21.27 |
Small Airway Epithelial Cells donor3 (cytoplasmic fraction) | 14316-155D5 |
626.42 | 0.00 | 15.84 |
Small Airway Epithelial Cells, donor1 | 11256-116F5 |
986.40 | 0.14 | 4.17 |
Small Airway Epithelial Cells, donor2 | 11334-117F2 |
695.13 | 0.28 | 8.72 |
Small Airway Epithelial Cells, donor3 (nuclear fraction) | 14317-155D6 |
332.60 | 0.21 | 6.77 |
Small Airway Epithelial Cells, donor3 | 11406-118E2 |
771.09 | 0.00 | 6.82 |
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction) | 14313-155D2 |
1217.36 | 0.31 | 41.97 |
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction) | 14314-155D3 |
275.02 | 0.00 | 8.00 |
Smooth Muscle Cells - Aortic, donor0 | 11210-116A4 |
897.02 | 0.00 | 10.58 |
Smooth Muscle Cells - Aortic, donor1 | 11283-116I5 |
549.83 | 0.00 | 2.65 |
Smooth Muscle Cells - Aortic, donor2 | 11360-117I1 |
1158.11 | 0.00 | 11.81 |
Smooth Muscle Cells - Aortic, donor3 | 11432-118H1 |
972.66 | 0.00 | 6.95 |
Smooth Muscle Cells - Bladder, donor1 | 11519-119H7 |
1186.90 | 1.00 | 6.00 |
Smooth Muscle Cells - Brachiocephalic, donor1 | 11284-116I6 |
891.62 | 0.00 | 6.79 |
Smooth Muscle Cells - Brachiocephalic, donor2 | 11361-117I2 |
993.23 | 0.00 | 10.64 |
Smooth Muscle Cells - Brachiocephalic, donor3 | 11433-118H2 |
1508.07 | 0.38 | 28.42 |
Smooth Muscle Cells - Brain Vascular, donor1 | 11234-116D1 |
786.63 | 0.00 | 7.49 |
Smooth Muscle Cells - Brain Vascular, donor2 | 11315-117D1 |
711.44 | 0.00 | 7.09 |
Smooth Muscle Cells - Brain Vascular, donor3 | 11391-118C5 |
744.42 | 0.00 | 11.10 |
Smooth Muscle Cells - Bronchial, donor1 | 11512-119G9 |
1045.18 | 0.16 | 28.63 |
Smooth Muscle Cells - Bronchial, donor2 | 11592-120G8 |
637.48 | 0.00 | 7.92 |
Smooth Muscle Cells - Carotid, donor1 | 11285-116I7 |
875.13 | 0.00 | 7.07 |
Smooth Muscle Cells - Carotid, donor2 | 11362-117I3 |
636.55 | 0.00 | 0.00 |
Smooth Muscle Cells - Carotid, donor3 | 11434-118H3 |
1270.77 | 0.00 | 20.03 |
Smooth Muscle Cells - Colonic, donor1 | 11239-116D6 |
780.87 | 0.00 | 6.05 |
Smooth Muscle Cells - Colonic, donor2 | 11320-117D6 |
993.33 | 0.43 | 12.91 |
Smooth Muscle Cells - Colonic, donor3 | 11396-118D1 |
1066.79 | 0.00 | 17.63 |
Smooth Muscle Cells - Coronary Artery, donor1 | 11286-116I8 |
1094.51 | 0.15 | 12.84 |
Smooth Muscle Cells - Coronary Artery, donor2 | 11363-117I4 |
1691.19 | 2.16 | 25.87 |
Smooth Muscle Cells - Coronary Artery, donor3 | 11435-118H4 |
1076.18 | 0.00 | 18.53 |
Smooth Muscle Cells - Esophageal, donor1 | 11508-119G5 |
1373.79 | 0.34 | 34.82 |
Smooth Muscle Cells - Esophageal, donor2 | 11588-120G4 |
961.82 | 0.00 | 2.43 |
Smooth Muscle Cells - Internal Thoracic Artery, donor1 | 11287-116I9 |
569.53 | 0.40 | 3.62 |
Smooth Muscle Cells - Internal Thoracic Artery, donor2 | 11364-117I5 |
783.24 | 0.00 | 9.10 |
Smooth Muscle Cells - Internal Thoracic Artery, donor3 | 11436-118H5 |
1194.94 | 0.00 | 19.32 |
Smooth Muscle Cells - Intestinal, donor1 | 11509-119G6 |
1366.22 | 0.00 | 28.88 |
Smooth Muscle Cells - Prostate, donor1 | 11257-116F6 |
895.10 | 0.00 | 12.65 |
Smooth Muscle Cells - Prostate, donor2 | 11335-117F3 |
893.19 | 0.50 | 9.02 |
Smooth Muscle Cells - Prostate, donor3 | 11465-119B7 |
724.97 | 0.00 | 1.52 |
Smooth Muscle Cells - Pulmonary Artery, donor1 | 11288-117A1 |
743.16 | 0.15 | 7.84 |
Smooth Muscle Cells - Pulmonary Artery, donor2 | 11365-117I6 |
1172.51 | 0.75 | 13.50 |
Smooth Muscle Cells - Pulmonary Artery, donor3 | 11437-118H6 |
722.35 | 0.00 | 16.80 |
Smooth Muscle Cells - Subclavian Artery, donor1 | 11289-117A2 |
690.16 | 0.00 | 10.23 |
Smooth Muscle Cells - Subclavian Artery, donor2 | 11366-117I7 |
1219.29 | 0.00 | 12.62 |
Smooth Muscle Cells - Subclavian Artery, donor3 | 11438-118H7 |
1029.50 | 0.00 | 10.34 |
Smooth Muscle Cells - Tracheal, donor1 | 11513-119H1 |
801.22 | 0.29 | 12.98 |
Smooth Muscle Cells - Tracheal, donor2 | 11593-120G9 |
967.28 | 0.00 | 12.16 |
Smooth Muscle Cells - Tracheal, donor3 | 11674-122G9 |
942.26 | 0.00 | 5.61 |
Smooth Muscle Cells - Umbilical Artery, donor1 | 11290-117A3 |
913.31 | 0.14 | 10.79 |
Smooth Muscle Cells - Umbilical Artery, donor2 | 11367-117I8 |
1356.11 | 0.51 | 21.93 |
Smooth Muscle Cells - Umbilical Artery, donor3 | 11439-118H8 |
1530.40 | 0.00 | 22.56 |
Smooth Muscle Cells - Umbilical Vein, donor1 | 11541-120B2 |
1071.14 | 0.00 | 12.02 |
Smooth Muscle Cells - Umbilical Vein, donor2 | 11621-122B1 |
996.24 | 0.00 | 7.29 |
Smooth Muscle Cells - Umbilical Vein, donor3 | 11702-123B1 |
1250.45 | 0.00 | 9.05 |
Smooth Muscle Cells - Umbilical artery, donor0 | 11212-116A6 |
948.31 | 0.00 | 9.30 |
Smooth Muscle Cells - Uterine, donor1 | 11258-116F7 |
1058.78 | 0.22 | 11.93 |
Smooth Muscle Cells - Uterine, donor3 | 11466-119B8 |
1296.71 | 0.00 | 9.36 |
Smooth muscle cells - airway, asthmatic, donor1 | 11960-126C7 |
424.68 | 0.00 | 6.03 |
Smooth muscle cells - airway, asthmatic, donor2 | 11961-126C8 |
502.99 | 0.00 | 15.34 |
Smooth muscle cells - airway, asthmatic, donor3 | 11962-126C9 |
602.93 | 0.37 | 15.62 |
Smooth muscle cells - airway, asthmatic, donor4 | 11963-126D1 |
562.72 | 0.00 | 11.50 |
Smooth muscle cells - airway, asthmatic, donor5 | 11964-126D2 |
558.71 | 0.00 | 21.01 |
Smooth muscle cells - airway, asthmatic, donor6 | 11965-126D3 |
818.46 | 0.00 | 51.99 |
Smooth muscle cells - airway, control, donor1 | 11966-126D4 |
535.84 | 0.00 | 12.44 |
Smooth muscle cells - airway, control, donor2 | 11967-126D5 |
563.44 | 0.00 | 5.59 |
Smooth muscle cells - airway, control, donor3 | 11968-126D6 |
753.25 | 0.42 | 12.54 |
Smooth muscle cells - airway, control, donor4 | 11969-126D7 |
603.66 | 0.00 | 10.54 |
Synoviocyte, donor1 | 11291-117A4 |
633.90 | 0.00 | 2.36 |
Synoviocyte, donor2 | 11368-117I9 |
725.81 | 0.00 | 3.69 |
Synoviocyte, donor3 | 11440-118H9 |
929.83 | 0.00 | 4.92 |
Trabecular Meshwork Cells, donor1 | 11532-120A2 |
1318.19 | 0.00 | 45.74 |
Trabecular Meshwork Cells, donor2 | 11612-122A1 |
1452.84 | 0.00 | 23.78 |
Trabecular Meshwork Cells, donor3 | 11693-123A1 |
1342.28 | 0.00 | 16.44 |
Tracheal Epithelial Cells, donor1 | 11292-117A5 |
1122.08 | 0.00 | 6.38 |
Tracheal Epithelial Cells, donor2 | 11369-118A1 |
1118.71 | 0.00 | 18.17 |
Tracheal Epithelial Cells, donor3 | 11441-118I1 |
980.97 | 0.00 | 10.88 |
Universal RNA - Human Normal Tissues Biochain, pool1 | 10007-101B4 |
605.16 | 0.00 | 2.46 |
Urethra, donor2 | 10319-105A4 |
829.07 | 0.00 | 0.00 |
Urothelial Cells, donor1 | 11520-119H8 |
846.93 | 0.00 | 16.47 |
Urothelial Cells, donor2 | 11600-120H7 |
1177.26 | 0.00 | 14.02 |
Urothelial Cells, donor3 | 11681-122H7 |
1171.70 | 0.46 | 7.56 |
Urothelial cells, donor0 | 11216-116B1 |
827.16 | 0.00 | 2.67 |
Whole blood (ribopure), donor090309, donation1 | 12179-129A1 |
825.72 | 0.00 | 0.89 |
Whole blood (ribopure), donor090309, donation2 | 12180-129A2 |
970.71 | 0.00 | 4.29 |
Whole blood (ribopure), donor090309, donation3 | 12181-129A3 |
676.99 | 0.00 | 0.68 |
Whole blood (ribopure), donor090325, donation1 | 12176-128I7 |
885.98 | 0.34 | 0.69 |
Whole blood (ribopure), donor090325, donation2 | 12177-128I8 |
1064.44 | 0.00 | 1.74 |
Whole blood (ribopure), donor090612, donation1 | 12182-129A4 |
730.95 | 0.00 | 2.08 |
Whole blood (ribopure), donor090612, donation2 | 12183-129A5 |
847.12 | 0.00 | 2.75 |
Whole blood (ribopure), donor090612, donation3 | 12184-129A6 |
813.39 | 0.00 | 0.91 |
Wilms' tumor cell line:G-401 | 10809-111A8 |
1159.84 | 0.25 | 22.58 |
Wilms' tumor cell line:HFWT | 10597-108E3 |
994.45 | 0.00 | 7.04 |
acantholytic squamous carcinoma cell line:HCC1806 | 10717-109I6 |
1234.59 | 0.56 | 13.41 |
achilles tendon, donor2 | 10292-104G4 |
591.03 | 0.00 | 8.27 |
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1 | 10455-106G5 |
1375.49 | 0.00 | 29.07 |
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6 | 10534-107G3 |
1949.57 | 2.09 | 37.15 |
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL | 10429-106D6 |
1173.43 | 0.12 | 7.83 |
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat | 10464-106H5 |
1270.77 | 0.27 | 20.68 |
acute myeloid leukemia (FAB M0) cell line:KG-1 | 10827-111C8 |
973.67 | 0.00 | 48.63 |
acute myeloid leukemia (FAB M0) cell line:Kasumi-3 | 10789-110H6 |
1567.08 | 0.21 | 13.32 |
acute myeloid leukemia (FAB M1) cell line:HYT-1 | 10828-111C9 |
744.50 | 0.00 | 7.08 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-1 | 10788-110H5 |
2184.69 | 0.00 | 51.55 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-6 | 10792-110H9 |
1198.94 | 0.00 | 32.67 |
acute myeloid leukemia (FAB M2) cell line:NKM-1 | 10765-110E9 |
2343.77 | 0.39 | 30.29 |
acute myeloid leukemia (FAB M3) cell line:HL60 | 10829-111D1 |
1546.15 | 0.55 | 73.23 |
acute myeloid leukemia (FAB M4) cell line:FKH-1 | 10830-111D2 |
1778.64 | 0.00 | 31.20 |
acute myeloid leukemia (FAB M4) cell line:HNT-34 | 10831-111D3 |
1613.43 | 0.23 | 63.21 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-1 | 10832-111D4 |
2704.74 | 0.78 | 94.24 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-3 | 10833-111D5 |
1338.48 | 0.29 | 40.33 |
acute myeloid leukemia (FAB M5) cell line:NOMO-1 | 10764-110E8 |
1021.08 | 0.00 | 23.24 |
acute myeloid leukemia (FAB M5) cell line:P31/FUJ | 10770-110F5 |
939.71 | 0.00 | 20.56 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction) | 14298-155B5 |
1179.61 | 0.00 | 29.16 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh) | 10399-106A3 |
1376.56 | 0.00 | 20.06 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived) | 10400-106A4 |
1152.21 | 0.00 | 13.65 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed) | 10405-106A9 |
1300.77 | 0.00 | 15.65 |
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4 | 10834-111D6 |
1040.19 | 0.45 | 59.69 |
acute myeloid leukemia (FAB M6) cell line:EEB | 10835-111D7 |
1272.82 | 0.00 | 49.36 |
acute myeloid leukemia (FAB M6) cell line:F-36E | 10836-111D8 |
1044.31 | 0.00 | 35.31 |
acute myeloid leukemia (FAB M6) cell line:F-36P | 10837-111D9 |
1148.44 | 0.00 | 44.07 |
acute myeloid leukemia (FAB M7) cell line:M-MOK | 10699-109G6 |
929.40 | 0.00 | 22.68 |
acute myeloid leukemia (FAB M7) cell line:MKPL-1 | 10802-111A1 |
781.65 | 0.00 | 46.86 |
adenocarcinoma cell line:IM95m | 10796-110I4 |
1159.37 | 0.00 | 20.49 |
adipose tissue, adult, pool1 | 10010-101C1 |
530.82 | 0.00 | 1.71 |
adipose, donor1 | 10184-103D4 |
2372.03 | 0.00 | 21.11 |
adipose, donor2 | 10185-103D5 |
2289.96 | 0.00 | 3.24 |
adipose, donor3 | 10186-103D6 |
1609.22 | 0.00 | 11.98 |
adipose, donor4 | 10187-103D7 |
1694.50 | 0.00 | 15.60 |
adrenal cortex adenocarcinoma cell line:SW-13 | 10810-111A9 |
812.46 | 0.16 | 11.68 |
adrenal gland, adult, pool1 | 10081-102A9 |
596.58 | 0.00 | 0.00 |
adult T-cell leukemia cell line:ATN-1 | 10421-106C7 |
908.23 | 0.13 | 4.14 |
alveolar cell carcinoma cell line:SW 1573 | 10708-109H6 |
1603.56 | 0.00 | 19.65 |
amniotic membrane cells, donor1 | 12235-129G3 |
598.64 | 0.00 | 6.49 |
amniotic membrane cells, donor2 | 12236-129G4 |
855.40 | 0.00 | 8.45 |
amniotic membrane cells, donor3 | 12237-129G5 |
1061.74 | 0.00 | 4.42 |
amygdala - adult, donor10196 | 10167-103B5 |
199.21 | 0.00 | 29.64 |
amygdala, adult, donor10252 | 10151-102I7 |
358.90 | 0.00 | 2.64 |
amygdala, newborn, donor10223 | 10360-105E9 |
401.85 | 0.00 | 9.36 |
anaplastic carcinoma cell line:8305C | 10428-106D5 |
1292.40 | 0.00 | 3.31 |
anaplastic large cell lymphoma cell line:Ki-JK | 10795-110I3 |
3340.68 | 1.10 | 69.72 |
anaplastic squamous cell carcinoma cell line:RPMI 2650 | 10805-111A4 |
1307.42 | 0.00 | 16.03 |
aorta, adult, pool1 | 10052-101G7 |
694.11 | 0.00 | 3.53 |
appendix, adult | 10189-103D9 |
955.55 | 0.00 | 7.37 |
argyrophil small cell carcinoma cell line:TC-YIK | 10589-108D4 |
1486.14 | 0.34 | 13.76 |
artery, adult | 10190-103E1 |
1093.74 | 0.00 | 2.72 |
astrocytoma cell line:TM-31 | 10425-106D2 |
1058.40 | 0.00 | 8.40 |
b cell line:RPMI1788 | 10427-106D4 |
1478.83 | 0.45 | 6.25 |
basal cell carcinoma cell line:TE 354.T | 10702-109G9 |
658.66 | 0.00 | 2.50 |
bile duct carcinoma cell line:HuCCT1 | 10432-106D9 |
984.08 | 0.00 | 8.63 |
bile duct carcinoma cell line:TFK-1 | 10496-107C1 |
903.01 | 0.00 | 3.68 |
biphenotypic B myelomonocytic leukemia cell line:MV-4-11 | 10718-109I7 |
1940.00 | 0.56 | 8.95 |
bladder, adult, pool1 | 10011-101C2 |
738.65 | 0.00 | 1.20 |
blood, adult, pool1 | 10053-101G8 |
1147.18 | 0.00 | 2.21 |
bone marrow stromal cell line:StromaNKtert | 10686-109F2 |
498.39 | 0.00 | 5.99 |
bone marrow, adult | 10192-103E3 |
690.35 | 0.00 | 4.72 |
brain, adult, donor1 | 10084-102B3 |
424.38 | 0.00 | 3.08 |
brain, adult, pool1 | 10012-101C3 |
324.39 | 0.00 | 2.45 |
brain, fetal, pool1 | 10085-102B4 |
1765.79 | 0.00 | 10.69 |
breast carcinoma cell line:MCF7 | 10482-107A5 |
1435.43 | 0.00 | 8.59 |
breast carcinoma cell line:MDA-MB-453 | 10419-106C5 |
623.99 | 0.00 | 5.62 |
breast, adult, donor1 | 10080-102A8 |
690.70 | 0.00 | 3.16 |
bronchial squamous cell carcinoma cell line:KNS-62 | 10760-110E4 |
807.45 | 0.25 | 16.64 |
bronchioalveolar carcinoma cell line:NCI-H358 | 10709-109H7 |
1541.15 | 0.00 | 4.33 |
bronchioalveolar carcinoma cell line:NCI-H650 | 10715-109I4 |
1635.71 | 0.00 | 9.67 |
bronchogenic carcinoma cell line:ChaGo-K-1 | 10710-109H8 |
1055.25 | 0.73 | 11.38 |
carcinoid cell line:NCI-H1770 | 10703-109H1 |
1534.63 | 0.47 | 9.40 |
carcinoid cell line:NCI-H727 | 10735-110B6 |
687.24 | 0.00 | 9.73 |
carcinoid cell line:SK-PN-DW | 10719-109I8 |
2062.36 | 0.63 | 19.96 |
carcinosarcoma cell line:JHUCS-1 | 10642-109A3 |
1611.17 | 0.00 | 12.78 |
caudate nucleus - adult, donor10196 | 10177-103C6 |
224.51 | 0.00 | 19.57 |
caudate nucleus, adult, donor10252 | 10164-103B2 |
394.72 | 0.00 | 5.02 |
caudate nucleus, adult, donor10258 | 10379-105H1 |
419.51 | 0.00 | 13.75 |
caudate nucleus, newborn, donor10223 | 10354-105E3 |
545.32 | 0.00 | 8.42 |
cerebellum - adult, donor10196 | 10173-103C2 |
337.94 | 0.00 | 5.83 |
cerebellum, adult, donor10252 | 10166-103B4 |
277.56 | 0.00 | 2.14 |
cerebellum, adult, pool1 | 10083-102B2 |
544.67 | 0.00 | 3.10 |
cerebellum, newborn, donor10223 | 10357-105E6 |
544.67 | 0.00 | 2.49 |
cerebral meninges, adult | 10188-103D8 |
576.14 | 0.00 | 5.80 |
cerebrospinal fluid, donor2 | 10294-104G6 |
575.21 | 1.46 | 5.85 |
cervical cancer cell line:D98-AH2 | 10552-107I3 |
1449.47 | 0.29 | 11.07 |
cervical cancer cell line:ME-180 | 10553-107I4 |
2044.11 | 0.17 | 14.58 |
cervix, adult, pool1 | 10013-101C4 |
846.43 | 0.00 | 2.52 |
cholangiocellular carcinoma cell line:HuH-28 | 10536-107G5 |
780.57 | 0.00 | 5.43 |
chondrosarcoma cell line:SW 1353 | 10700-109G7 |
561.69 | 0.00 | 3.92 |
choriocarcinoma cell line:BeWo | 10423-106C9 |
1688.91 | 0.00 | 5.97 |
choriocarcinoma cell line:SCH | 10785-110H2 |
653.27 | 0.00 | 6.78 |
choriocarcinoma cell line:T3M-3 | 10618-108G6 |
797.87 | 0.00 | 12.10 |
chorionic membrane cells, donor1 | 12238-129G6 |
499.75 | 0.00 | 4.84 |
chorionic membrane cells, donor2 | 12239-129G7 |
555.02 | 0.00 | 8.45 |
chorionic membrane cells, donor3 | 12240-129G8 |
781.92 | 0.00 | 5.49 |
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3 | 10416-106C2 |
1754.03 | 2.02 | 42.41 |
chronic myeloblastic leukemia (CML) cell line:KCL-22 | 10801-110I9 |
1400.59 | 0.19 | 39.19 |
chronic myelogenous leukemia (CML) cell line:MEG-A2 | 10766-110F1 |
1285.70 | 0.21 | 23.02 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1 | 10824-111C5 |
980.47 | 1.80 | 33.64 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2 | 10825-111C6 |
1032.58 | 0.48 | 31.44 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3 | 10826-111C7 |
900.97 | 0.20 | 32.58 |
chronic myelogenous leukemia cell line:K562 | 10454-106G4 |
1563.85 | 0.59 | 15.90 |
chronic myelogenous leukemia cell line:KU812 | 10409-106B4 |
951.28 | 0.00 | 10.16 |
clear cell carcinoma cell line:JHOC-5 | 10638-108I8 |
750.89 | 0.00 | 9.60 |
clear cell carcinoma cell line:TEN | 10636-108I6 |
922.36 | 0.00 | 3.47 |
colon carcinoma cell line:CACO-2 | 10513-107D9 |
1077.57 | 0.37 | 13.36 |
colon carcinoma cell line:COLO-320 | 10420-106C6 |
2061.18 | 0.38 | 10.64 |
colon, adult, donor1 | 10082-102B1 |
1009.15 | 0.00 | 5.95 |
colon, adult, pool1 | 10014-101C5 |
851.19 | 0.00 | 2.23 |
colon, fetal, donor1 | 10070-101I7 |
757.04 | 0.00 | 4.33 |
common myeloid progenitor CMP, donor1 | 12130-128D6 |
1879.24 | 0.00 | 4.58 |
common myeloid progenitor CMP, donor2 | 12134-128E1 |
7986.71 | 0.00 | 25.04 |
cord blood derived cell line:COBL-a 24h infection(-C) | 10452-106G2 |
875.79 | 0.00 | 6.80 |
cord blood derived cell line:COBL-a 24h infection | 10453-106G3 |
966.41 | 0.15 | 12.98 |
cord blood derived cell line:COBL-a untreated | 10449-106F8 |
1053.78 | 0.42 | 17.49 |
corpus callosum, adult, pool1 | 10042-101F6 |
400.57 | 0.00 | 1.99 |
cruciate ligament, donor2 | 10295-104G7 |
595.70 | 0.00 | 8.10 |
diaphragm, fetal, donor1 | 10069-101I6 |
825.03 | 0.00 | 8.03 |
diencephalon, adult | 10193-103E4 |
355.42 | 0.00 | 6.24 |
diffuse large B-cell lymphoma cell line:CTB-1 | 10631-108I1 |
2302.54 | 0.69 | 31.92 |
ductal cell carcinoma cell line:KLM-1 | 10438-106E6 |
1141.16 | 0.00 | 9.23 |
ductal cell carcinoma cell line:MIA Paca2 | 10488-107B2 |
1257.05 | 0.48 | 5.78 |
ductus deferens, adult | 10196-103E7 |
584.05 | 0.00 | 3.49 |
duodenum, fetal, donor1, tech_rep1 | 10071-101I8 |
1008.16 | 0.00 | 7.20 |
duodenum, fetal, donor1, tech_rep2 | 10071-101I8 |
786.41 | 0.00 | 10.30 |
dura mater, adult, donor1 | 10041-101F5 |
660.20 | 0.00 | 2.31 |
embryonic kidney cell line: HEK293/SLAM infection, 24hr | 10451-106G1 |
1077.50 | 2.22 | 10.88 |
embryonic kidney cell line: HEK293/SLAM untreated | 10450-106F9 |
1284.48 | 0.14 | 12.61 |
embryonic pancreas cell line:1B2C6 | 10604-108F1 |
1507.62 | 0.00 | 11.72 |
embryonic pancreas cell line:1C3D3 | 10605-108F2 |
1696.69 | 0.00 | 6.05 |
embryonic pancreas cell line:1C3IKEI | 10606-108F3 |
1651.50 | 0.00 | 12.35 |
embryonic pancreas cell line:2C6 | 10603-108E9 |
1798.13 | 0.00 | 27.58 |
endometrial carcinoma cell line:OMC-2 | 10497-107C2 |
1024.36 | 0.00 | 8.04 |
endometrial stromal sarcoma cell line:OMC-9 | 10448-106F7 |
990.63 | 0.00 | 2.54 |
endometrioid adenocarcinoma cell line:JHUEM-1 | 10643-109A4 |
991.25 | 0.00 | 19.14 |
epidermoid carcinoma cell line:A431 | 10426-106D3 |
1009.76 | 0.11 | 7.23 |
epidermoid carcinoma cell line:Ca Ski | 10431-106D8 |
1214.46 | 0.00 | 13.75 |
epididymis, adult | 10197-103E8 |
660.59 | 0.00 | 2.72 |
epithelioid sarcoma cell line:HS-ES-1 | 10443-106F2 |
697.75 | 0.00 | 3.90 |
epithelioid sarcoma cell line:HS-ES-2R | 10495-107B9 |
655.93 | 0.00 | 14.94 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1 | 10815-111B5 |
2178.70 | 0.13 | 25.82 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2 | 10816-111B6 |
1878.94 | 0.39 | 17.22 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3 | 10817-111B7 |
2283.39 | 0.22 | 28.57 |
esophagus, adult, pool1 | 10015-101C6 |
916.63 | 0.11 | 2.34 |
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS | 10410-106B5 |
1267.64 | 0.00 | 3.26 |
eye - muscle inferior rectus, donor1 | 10272-104E2 |
437.04 | 0.00 | 7.24 |
eye - muscle lateral, donor2 | 10298-104H1 |
460.82 | 0.00 | 2.10 |
eye - muscle medial, donor2 | 10299-104H2 |
337.82 | 0.00 | 2.98 |
eye - muscle superior, donor2 | 10297-104G9 |
445.99 | 0.00 | 9.17 |
eye - vitreous humor, donor1 | 10268-104D7 |
542.15 | 0.00 | 8.74 |
eye, fetal, donor1 | 10054-101G9 |
704.74 | 0.00 | 3.81 |
fibrosarcoma cell line:HT-1080 | 10758-110E2 |
979.38 | 0.13 | 14.87 |
fibrous histiocytoma cell line:GCT TIB-223 | 10711-109H9 |
1004.76 | 0.00 | 18.76 |
frontal lobe, adult, pool1 | 10040-101F4 |
280.06 | 0.00 | 2.72 |
gall bladder carcinoma cell line:TGBC14TKB | 10470-106I2 |
686.07 | 0.00 | 8.11 |
gall bladder carcinoma cell line:TGBC2TKB | 10415-106C1 |
568.83 | 0.00 | 2.29 |
gall bladder, adult | 10198-103E9 |
566.40 | 0.00 | 2.66 |
gamma delta positive T cells, donor1 | 11937-126A2 |
1851.61 | 0.00 | 12.35 |
gamma delta positive T cells, donor2 | 11938-126A3 |
1148.86 | 0.00 | 7.47 |
gastric adenocarcinoma cell line:MKN1 | 10614-108G2 |
1362.35 | 0.00 | 17.53 |
gastric adenocarcinoma cell line:MKN45 | 10612-108F9 |
1237.67 | 0.19 | 10.64 |
gastric cancer cell line:AZ521 | 10549-107H9 |
982.75 | 0.00 | 10.82 |
gastric cancer cell line:GSS | 10560-108A2 |
1037.87 | 0.00 | 17.39 |
gastrointestinal carcinoma cell line:ECC12 | 10615-108G3 |
800.97 | 0.00 | 7.08 |
giant cell carcinoma cell line:LU65 | 10487-107B1 |
1799.48 | 0.23 | 9.87 |
giant cell carcinoma cell line:Lu99B | 10433-106E1 |
1037.94 | 0.00 | 3.22 |
glassy cell carcinoma cell line:HOKUG | 10688-109F4 |
1183.49 | 0.00 | 14.72 |
glioblastoma cell line:A172, tech_rep1 | 10444-106F3 |
579.90 | 0.00 | 6.12 |
glioblastoma cell line:A172, tech_rep2 | 10444-106F3 |
630.57 | 0.00 | 6.88 |
glioblastoma cell line:T98G | 10485-107A8 |
699.33 | 0.00 | 5.41 |
glioma cell line:GI-1 | 10413-106B8 |
596.30 | 0.29 | 4.69 |
globus pallidus - adult, donor10196 | 10175-103C4 |
430.06 | 0.00 | 14.58 |
globus pallidus, adult, donor10252 | 10161-103A8 |
514.80 | 0.00 | 3.42 |
globus pallidus, adult, donor10258 | 10367-105F7 |
921.48 | 0.00 | 6.85 |
globus pallidus, newborn, donor10223 | 10364-105F4 |
633.64 | 0.00 | 8.53 |
granulocyte macrophage progenitor, donor1 | 12131-128D7 |
1928.35 | 0.00 | 4.89 |
granulocyte macrophage progenitor, donor2 | 12135-128E2 |
5245.62 | 0.00 | 21.86 |
granulocyte macrophage progenitor, donor3 | 12139-128E6 |
7050.66 | 0.00 | 20.91 |
granulosa cell tumor cell line:KGN | 10624-108H3 |
613.75 | 0.00 | 10.88 |
hIPS +CCl2, biol_rep1 | 14383-156B9 |
994.44 | 0.46 | 103.30 |
hIPS +CCl2, biol_rep2 | 14384-156C1 |
576.15 | 0.00 | 110.66 |
hIPS +CCl2, biol_rep3 | 14385-156C2 |
932.00 | 0.00 | 287.27 |
hIPS, biol_rep1 | 14380-156B6 |
353.57 | 2.87 | 705.71 |
hIPS, biol_rep2 | 14381-156B7 |
877.22 | 0.00 | 290.12 |
hIPS, biol_rep3 | 14382-156B8 |
297.94 | 1.10 | 39.72 |
hairy cell leukemia cell line:Mo | 10712-109I1 |
1243.91 | 0.00 | 10.92 |
heart - mitral valve, adult | 10205-103F7 |
473.27 | 0.00 | 3.89 |
heart - pulmonic valve, adult | 10206-103F8 |
468.56 | 0.00 | 3.14 |
heart - tricuspid valve, adult | 10207-103F9 |
651.96 | 0.00 | 6.66 |
heart, adult, diseased post-infarction, donor1 | 10050-101G5 |
499.94 | 0.00 | 4.29 |
heart, adult, diseased, donor1 | 10051-101G6 |
601.70 | 0.00 | 3.83 |
heart, adult, pool1 | 10016-101C7 |
592.19 | 0.00 | 2.76 |
heart, fetal, pool1 | 10046-101G1 |
669.99 | 0.00 | 3.18 |
hepatic mesenchymal tumor cell line:LI90 | 10778-110G4 |
522.64 | 0.00 | 8.95 |
hepatoblastoma cell line:HuH-6 | 10633-108I3 |
1878.90 | 0.00 | 13.08 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1 | 10818-111B8 |
983.52 | 0.11 | 15.91 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2 | 10819-111B9 |
967.23 | 0.24 | 14.93 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3 | 10820-111C1 |
918.27 | 0.00 | 13.64 |
hepatoma cell line:Li-7 | 10484-107A7 |
694.54 | 0.00 | 7.67 |
hereditary spherocytic anemia cell line:WIL2-NS | 10808-111A7 |
1693.83 | 1.31 | 51.05 |
hippocampus - adult, donor10196 | 10169-103B7 |
308.50 | 0.00 | 13.25 |
hippocampus, adult, donor10252 | 10153-102I9 |
349.21 | 0.00 | 1.84 |
hippocampus, adult, donor10258 | 10374-105G5 |
115.52 | 0.00 | 31.87 |
hippocampus, newborn, donor10223 | 10363-105F3 |
335.21 | 0.00 | 4.93 |
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1 | 13421-144D1 |
2394.99 | 0.61 | 111.08 |
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2 | 13425-144D5 |
1922.51 | 0.20 | 24.15 |
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3 | 13429-144D9 |
1806.21 | 0.00 | 44.18 |
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1 | 13422-144D2 |
1926.16 | 0.00 | 23.68 |
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2 | 13426-144D6 |
1948.46 | 0.26 | 13.17 |
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3 | 13430-144E1 |
1709.00 | 0.00 | 17.84 |
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1 | 13423-144D3 |
1491.01 | 0.29 | 17.23 |
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2 | 13427-144D7 |
1525.23 | 0.00 | 6.46 |
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3 | 13431-144E2 |
1423.47 | 0.42 | 17.10 |
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1 | 13424-144D4 |
1225.17 | 0.00 | 18.00 |
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2 | 13428-144D8 |
1503.03 | 0.00 | 15.91 |
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3 | 13432-144E3 |
1277.25 | 0.00 | 17.51 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1 | 13433-144E4 |
1584.09 | 0.00 | 21.44 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2 | 13437-144E8 |
1685.14 | 0.00 | 62.89 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3 | 13441-144F3 |
2215.05 | 0.00 | 85.53 |
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1 | 13434-144E5 |
1529.19 | 0.00 | 11.26 |
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2 | 13438-144E9 |
1292.96 | 0.00 | 16.57 |
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3 | 13442-144F4 |
1872.11 | 0.50 | 31.98 |
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1 | 13435-144E6 |
1373.19 | 0.19 | 4.14 |
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2 | 13439-144F1 |
1419.17 | 0.00 | 10.91 |
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3 | 13443-144F5 |
1564.93 | 0.00 | 12.84 |
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1 | 13436-144E7 |
1093.47 | 0.00 | 10.45 |
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2 | 13440-144F2 |
1035.53 | 0.00 | 18.58 |
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3 | 13444-144F6 |
1181.64 | 0.00 | 17.64 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1 | 13445-144F7 |
1688.38 | 0.18 | 26.42 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2 | 13449-144G2 |
1615.28 | 0.29 | 45.36 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3 | 13453-144G6 |
2208.97 | 0.41 | 84.11 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1 | 13446-144F8 |
1259.39 | 0.70 | 31.34 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2 | 13450-144G3 |
1232.12 | 0.00 | 16.79 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3 | 13454-144G7 |
1344.24 | 0.30 | 21.18 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1 | 13447-144F9 |
1181.62 | 0.00 | 10.34 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2 | 13451-144G4 |
1214.10 | 0.66 | 8.63 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3 | 13455-144G8 |
1234.95 | 0.00 | 12.31 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1 | 13448-144G1 |
1061.45 | 0.00 | 22.50 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2 | 13452-144G5 |
1468.26 | 0.00 | 25.75 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3 | 13456-144G9 |
1290.12 | 0.00 | 29.91 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1 | 13457-144H1 |
1659.39 | 0.24 | 39.61 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2 | 13461-144H5 |
1959.12 | 0.00 | 54.37 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3 | 13465-144H9 |
1941.97 | 0.00 | 67.81 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1 | 13458-144H2 |
1270.45 | 0.00 | 13.45 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2 | 13462-144H6 |
1483.48 | 0.00 | 65.06 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3 | 13466-144I1 |
1777.49 | 0.00 | 25.81 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1 | 13459-144H3 |
1459.10 | 0.55 | 11.49 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2 | 13463-144H7 |
1445.37 | 0.00 | 11.22 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3 | 13467-144I2 |
1201.42 | 0.00 | 11.03 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1 | 13460-144H4 |
1297.21 | 0.00 | 10.74 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2 | 13464-144H8 |
1030.18 | 0.14 | 11.24 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3 | 13468-144I3 |
1238.68 | 0.00 | 22.09 |
immature langerhans cells, donor1 | 11904-125F5 |
893.28 | 0.00 | 10.90 |
immature langerhans cells, donor2 | 11905-125F6 |
1280.09 | 0.00 | 7.13 |
insula, adult, pool1 | 10039-101F3 |
316.17 | 0.00 | 2.93 |
keratoacanthoma cell line:HKA-1 | 10791-110H8 |
2294.57 | 0.00 | 27.64 |
kidney, adult, pool1 | 10017-101C8 |
496.93 | 0.00 | 3.40 |
kidney, fetal, pool1 | 10045-101F9 |
593.97 | 0.00 | 2.26 |
large cell lung carcinoma cell line:IA-LM | 10509-107D5 |
1563.79 | 0.00 | 8.10 |
large cell lung carcinoma cell line:NCI-H460 | 10839-111E2 |
1677.84 | 0.14 | 12.30 |
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF | 10692-109F8 |
1650.58 | 0.00 | 9.73 |
left atrium, adult, donor1 | 10079-102A7 |
524.69 | 0.00 | 2.18 |
left ventricle, adult, donor1 | 10078-102A6 |
539.03 | 0.00 | 6.07 |
leiomyoblastoma cell line:G-402 | 10721-110A1 |
1378.99 | 0.82 | 31.47 |
leiomyoma cell line:10964C | 10569-108B2 |
1086.73 | 0.00 | 6.11 |
leiomyoma cell line:15242A | 10570-108B3 |
788.59 | 0.54 | 4.89 |
leiomyoma cell line:15425 | 10571-108B4 |
798.62 | 0.00 | 5.10 |
leiomyosarcoma cell line:Hs 5.T | 10722-110A2 |
977.80 | 0.00 | 0.00 |
lens epithelial cell line:SRA 01/04 | 10647-109A8 |
750.71 | 0.00 | 1.05 |
leukemia, chronic megakaryoblastic cell line:MEG-01 | 10752-110D5 |
1430.98 | 0.12 | 22.79 |
liposarcoma cell line:KMLS-1 | 10782-110G8 |
691.85 | 0.31 | 6.56 |
liposarcoma cell line:SW 872 | 10726-110A6 |
989.21 | 0.00 | 13.16 |
liver, adult, pool1 | 10018-101C9 |
685.84 | 0.00 | 5.51 |
liver, fetal, pool1 | 10086-102B5 |
610.52 | 0.00 | 1.88 |
locus coeruleus - adult, donor10196 | 10182-103D2 |
341.52 | 0.00 | 2.48 |
locus coeruleus, adult, donor10252 | 10165-103B3 |
369.84 | 0.00 | 0.92 |
locus coeruleus, adult, donor10258 | 10375-105G6 |
349.00 | 0.00 | 6.21 |
locus coeruleus, newborn, donor10223 | 10362-105F2 |
417.67 | 0.00 | 11.78 |
lung adenocarcinoma cell line:A549 | 10499-107C4 |
478.02 | 0.00 | 2.49 |
lung adenocarcinoma cell line:PC-14 | 10408-106B3 |
905.19 | 0.00 | 4.14 |
lung adenocarcinoma, papillary cell line:NCI-H441 | 10742-110C4 |
922.58 | 0.00 | 11.20 |
lung, adult, pool1 | 10019-101D1 |
680.77 | 0.00 | 1.18 |
lung, fetal, donor1 | 10068-101I5 |
656.72 | 0.00 | 5.14 |
lung, right lower lobe, adult, donor1 | 10075-102A3 |
577.35 | 0.00 | 2.75 |
lymph node, adult, donor1 | 10077-102A5 |
1132.76 | 0.00 | 6.15 |
lymphangiectasia cell line:DS-1 | 10727-110A7 |
1152.87 | 0.44 | 14.25 |
lymphoma, malignant, hairy B-cell cell line:MLMA | 10775-110G1 |
1280.46 | 0.00 | 14.79 |
malignant trichilemmal cyst cell line:DJM-1 | 10412-106B7 |
1450.94 | 0.00 | 5.95 |
mature adipocyte, donor1 | 12231-129F8 |
638.46 | 0.00 | 3.55 |
mature adipocyte, donor2 | 12232-129F9 |
522.97 | 0.00 | 3.11 |
mature adipocyte, donor3 | 12233-129G1 |
452.55 | 0.00 | 4.27 |
mature adipocyte, donor4 | 12234-129G2 |
761.49 | 0.00 | 2.11 |
maxillary sinus tumor cell line:HSQ-89 | 10414-106B9 |
1153.89 | 0.00 | 5.24 |
medial frontal gyrus - adult, donor10196 | 10170-103B8 |
278.62 | 0.00 | 12.41 |
medial frontal gyrus, adult, donor10252 | 10150-102I6 |
290.20 | 0.00 | 2.76 |
medial frontal gyrus, adult, donor10258 | 10368-105F8 |
386.31 | 0.00 | 11.75 |
medial frontal gyrus, newborn, donor10223 | 10352-105E1 |
440.99 | 0.43 | 14.93 |
medial temporal gyrus - adult, donor10196 | 10183-103D3 |
402.13 | 0.00 | 5.23 |
medial temporal gyrus, adult, donor10252 | 10156-103A3 |
312.82 | 0.00 | 3.82 |
medial temporal gyrus, adult, donor10258, tech_rep1 | 10376-105G7 |
202.26 | 0.00 | 63.57 |
medial temporal gyrus, adult, donor10258, tech_rep2 | 10376-105G7 |
114.83 | 0.00 | 0.00 |
medial temporal gyrus, newborn, donor10223 | 10353-105E2 |
433.95 | 0.00 | 8.26 |
medulla oblongata - adult, donor10196 | 10174-103C3 |
292.69 | 0.00 | 14.93 |
medulla oblongata, adult, donor10252 | 10155-103A2 |
316.57 | 0.00 | 1.39 |
medulla oblongata, adult, pool1 | 10038-101F2 |
273.29 | 0.00 | 1.63 |
medulla oblongata, newborn, donor10223 | 10361-105F1 |
381.20 | 0.00 | 8.68 |
medulloblastoma cell line:D283 Med | 10838-111E1 |
1713.95 | 0.22 | 16.83 |
medulloblastoma cell line:ONS-76 | 10759-110E3 |
675.56 | 0.00 | 17.61 |
melanoma cell line:COLO 679 | 10514-107E1 |
623.28 | 0.29 | 11.21 |
melanoma cell line:G-361 | 10465-106H6 |
1201.76 | 0.00 | 13.30 |
meningioma cell line:HKBMM | 10691-109F7 |
1144.04 | 0.00 | 5.97 |
merkel cell carcinoma cell line:MKL-1 | 10843-111E6 |
1075.01 | 0.00 | 10.57 |
merkel cell carcinoma cell line:MS-1 | 10844-111E7 |
882.91 | 0.00 | 16.59 |
mesenchymal precursor cell - adipose, donor1 | 11747-123G1 |
1300.35 | 0.15 | 15.19 |
mesenchymal precursor cell - adipose, donor2 | 11748-123G2 |
1062.14 | 0.00 | 5.82 |
mesenchymal precursor cell - adipose, donor3 | 11749-123G3 |
948.30 | 0.41 | 12.84 |
mesenchymal precursor cell - bone marrow, donor1 | 11750-123G4 |
721.06 | 0.28 | 4.64 |
mesenchymal precursor cell - bone marrow, donor2 | 11751-123G5 |
883.89 | 0.00 | 7.32 |
mesenchymal precursor cell - bone marrow, donor3 | 11840-124H4 |
633.00 | 0.69 | 9.72 |
mesenchymal precursor cell - cardiac, donor1 | 11752-123G6 |
861.43 | 0.00 | 4.46 |
mesenchymal precursor cell - cardiac, donor2 | 11753-123G7 |
873.89 | 0.12 | 5.87 |
mesenchymal precursor cell - cardiac, donor3 | 11754-123G8 |
886.68 | 0.00 | 12.47 |
mesenchymal precursor cell - cardiac, donor4 | 11755-123G9 |
838.19 | 0.00 | 9.72 |
mesenchymal precursor cell - ovarian cancer left ovary, donor1 | 11756-123H1 |
622.97 | 0.00 | 5.98 |
mesenchymal precursor cell - ovarian cancer left ovary, donor2 | 11833-124G6 |
463.73 | 0.00 | 4.61 |
mesenchymal precursor cell - ovarian cancer left ovary, donor3 | 11760-123H5 |
840.61 | 0.00 | 9.41 |
mesenchymal precursor cell - ovarian cancer left ovary, donor4 | 11836-124G9 |
662.21 | 0.00 | 17.80 |
mesenchymal precursor cell - ovarian cancer metastasis, donor1 | 11758-123H3 |
798.28 | 0.00 | 6.33 |
mesenchymal precursor cell - ovarian cancer metastasis, donor2 | 11835-124G8 |
444.65 | 0.00 | 7.19 |
mesenchymal precursor cell - ovarian cancer metastasis, donor3 | 11762-123H7 |
625.87 | 0.00 | 4.55 |
mesenchymal precursor cell - ovarian cancer metastasis, donor4 | 11838-124H2 |
354.76 | 0.00 | 8.66 |
mesenchymal precursor cell - ovarian cancer right ovary, donor1 | 11757-123H2 |
644.02 | 0.00 | 10.91 |
mesenchymal precursor cell - ovarian cancer right ovary, donor2 | 11759-123H4 |
760.79 | 0.00 | 7.62 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02) | 11761-123H6 |
703.13 | 0.00 | 6.56 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G) | 11842-124H6 |
478.61 | 0.00 | 7.00 |
mesenchymal precursor cell - ovarian cancer right ovary, donor4 | 11837-124H1 |
476.17 | 0.00 | 7.44 |
mesenchymal stem cell line:Hu5/E18 | 10568-108B1 |
1137.16 | 0.00 | 10.95 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1 | 13229-141I7 |
998.28 | 0.00 | 18.27 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2 | 13230-141I8 |
723.87 | 0.00 | 9.21 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3 | 13231-141I9 |
776.11 | 0.00 | 10.21 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1 | 13232-142A1 |
717.84 | 0.00 | 7.39 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2 | 13233-142A2 |
697.83 | 0.00 | 8.47 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3 | 13234-142A3 |
791.65 | 0.00 | 10.83 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1 | 13235-142A4 |
773.76 | 0.00 | 6.29 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2 | 13236-142A5 |
679.79 | 0.46 | 7.41 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3 | 13237-142A6 |
1062.68 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1 | 13238-142A7 |
834.97 | 0.00 | 10.38 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2 | 13239-142A8 |
713.25 | 0.00 | 10.71 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3 | 13240-142A9 |
732.35 | 0.24 | 6.25 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1 | 13241-142B1 |
775.13 | 0.00 | 11.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2 | 13242-142B2 |
732.07 | 0.00 | 8.39 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3 | 13243-142B3 |
733.20 | 0.00 | 8.19 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1 | 13244-142B4 |
780.94 | 0.00 | 6.87 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2 | 13245-142B5 |
1082.83 | 0.00 | 16.41 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3 | 13246-142B6 |
955.52 | 0.00 | 15.49 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1 | 13247-142B7 |
864.26 | 0.00 | 17.86 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2 | 13248-142B8 |
887.54 | 0.00 | 18.91 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3 | 13249-142B9 |
1040.57 | 0.00 | 14.93 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1 | 13250-142C1 |
984.60 | 0.00 | 14.72 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2 | 13251-142C2 |
862.18 | 0.00 | 17.88 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3 | 13252-142C3 |
898.26 | 0.00 | 23.09 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1 | 13253-142C4 |
896.11 | 0.00 | 9.93 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2 | 13254-142C5 |
948.68 | 0.00 | 9.53 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3 | 13255-142C6 |
860.99 | 0.00 | 20.75 |
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1 | 13256-142C7 |
978.42 | 0.00 | 18.28 |
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2 | 13257-142C8 |
811.57 | 0.00 | 27.05 |
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3 | 13258-142C9 |
1016.58 | 0.00 | 13.30 |
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1 | 13259-142D1 |
905.37 | 0.00 | 10.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2 | 13260-142D2 |
919.86 | 0.00 | 2.15 |
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3 | 13261-142D3 |
993.96 | 0.00 | 7.98 |
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1 | 13262-142D4 |
767.99 | 0.00 | 24.11 |
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2 | 13263-142D5 |
1051.68 | 0.00 | 8.56 |
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3 | 13264-142D6 |
1066.94 | 0.00 | 10.33 |
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1 | 13265-142D7 |
1038.16 | 0.00 | 7.07 |
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2 | 13266-142D8 |
1024.88 | 0.00 | 10.60 |
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3 | 13267-142D9 |
1002.50 | 0.00 | 9.36 |
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1 | 13268-142E1 |
1091.61 | 0.00 | 9.46 |
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2 | 13269-142E2 |
896.23 | 0.00 | 25.68 |
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3 | 13270-142E3 |
945.17 | 0.00 | 18.59 |
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1 | 13271-142E4 |
910.45 | 0.00 | 15.83 |
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2 | 13272-142E5 |
1009.36 | 0.00 | 6.73 |
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3 | 13273-142E6 |
1025.97 | 0.00 | 14.63 |
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1 | 13274-142E7 |
821.68 | 0.00 | 14.51 |
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2 | 13275-142E8 |
911.49 | 0.00 | 4.36 |
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3 | 13276-142E9 |
899.61 | 0.00 | 8.87 |
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1 | 13277-142F1 |
586.25 | 0.00 | 4.25 |
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2 | 13278-142F2 |
840.53 | 0.00 | 4.52 |
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3 | 13279-142F3 |
622.70 | 0.00 | 9.06 |
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1 | 13280-142F4 |
820.49 | 0.00 | 5.56 |
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2 | 13281-142F5 |
827.13 | 0.00 | 15.25 |
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3 | 13282-142F6 |
885.19 | 0.00 | 11.20 |
mesodermal tumor cell line:HIRS-BM | 10696-109G3 |
740.44 | 0.00 | 3.09 |
mesothelioma cell line:ACC-MESO-1 | 10493-107B7 |
1003.55 | 0.00 | 3.31 |
mesothelioma cell line:ACC-MESO-4 | 10494-107B8 |
886.38 | 0.70 | 8.34 |
mesothelioma cell line:Mero-14, tech_rep1 | 10849-111F3 |
884.63 | 0.00 | 12.82 |
mesothelioma cell line:Mero-14, tech_rep2 | 10849-111F3 |
2147.89 | 0.10 | 12.23 |
mesothelioma cell line:Mero-25 | 10850-111F4 |
1400.99 | 0.00 | 30.87 |
mesothelioma cell line:Mero-41 | 10851-111F5 |
815.57 | 0.00 | 18.82 |
mesothelioma cell line:Mero-48a | 10852-111F6 |
838.78 | 0.00 | 29.01 |
mesothelioma cell line:Mero-82 | 10853-111F7 |
1089.85 | 0.26 | 32.85 |
mesothelioma cell line:Mero-83 | 10854-111F8 |
767.87 | 0.17 | 25.70 |
mesothelioma cell line:Mero-84 | 10855-111F9 |
1086.42 | 0.00 | 26.54 |
mesothelioma cell line:Mero-95 | 10856-111G1 |
621.96 | 0.00 | 14.29 |
mesothelioma cell line:NCI-H2052 | 10847-111F1 |
992.06 | 0.00 | 23.36 |
mesothelioma cell line:NCI-H226 | 10846-111E9 |
1190.20 | 0.72 | 41.45 |
mesothelioma cell line:NCI-H2452 | 10848-111F2 |
925.51 | 0.00 | 21.35 |
mesothelioma cell line:NCI-H28 | 10845-111E8 |
1363.17 | 0.00 | 31.55 |
mesothelioma cell line:No36 | 10857-111G2 |
862.81 | 0.00 | 24.47 |
mesothelioma cell line:ONE58 | 10858-111G3 |
1262.91 | 0.27 | 24.93 |
migratory langerhans cells, donor1 | 11901-125F2 |
435.09 | 0.00 | 6.53 |
migratory langerhans cells, donor2 | 11902-125F3 |
289.90 | 0.00 | 4.03 |
migratory langerhans cells, donor3 | 11903-125F4 |
643.44 | 0.00 | 6.64 |
mixed mullerian tumor cell line:HTMMT | 10689-109F5 |
1162.92 | 0.00 | 3.59 |
mucinous adenocarcinoma cell line:JHOM-1 | 10648-109A9 |
949.47 | 0.00 | 13.78 |
mucinous cystadenocarcinoma cell line:MCAS | 10784-110H1 |
1043.52 | 0.00 | 15.20 |
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162 | 10744-110C6 |
696.66 | 0.00 | 16.17 |
myelodysplastic syndrome cell line:SKM-1 | 10772-110F7 |
2081.13 | 0.37 | 15.34 |
myeloma cell line:PCM6 | 10474-106I6 |
1770.50 | 0.79 | 8.50 |
myxofibrosarcoma cell line:MFH-ino | 10600-108E6 |
879.13 | 0.00 | 15.22 |
myxofibrosarcoma cell line:NMFH-1 | 10684-109E9 |
1150.55 | 0.00 | 44.13 |
nasal epithelial cells, donor1, tech_rep1 | 12226-129F3 |
1484.73 | 0.11 | 2.45 |
nasal epithelial cells, donor1, tech_rep2 | 12226-129F3 |
1363.07 | 0.07 | 4.56 |
nasal epithelial cells, donor2 | 12227-129F4 |
901.40 | 0.00 | 1.66 |
neuroblastoma cell line:CHP-134 | 10508-107D4 |
1781.13 | 0.00 | 7.36 |
neuroblastoma cell line:NB-1 | 10539-107G8 |
946.65 | 0.00 | 15.15 |
neuroblastoma cell line:NBsusSR | 10607-108F4 |
851.57 | 0.00 | 25.10 |
neuroblastoma cell line:NH-12 | 10555-107I6 |
2120.12 | 0.00 | 25.72 |
neuroectodermal tumor cell line:FU-RPNT-1 | 10637-108I7 |
1013.67 | 0.00 | 5.22 |
neuroectodermal tumor cell line:FU-RPNT-2 | 10663-109C6 |
1364.13 | 0.00 | 7.76 |
neuroectodermal tumor cell line:TASK1 | 10774-110F9 |
1556.14 | 0.00 | 15.09 |
neuroepithelioma cell line:SK-N-MC | 10728-110A8 |
1024.22 | 0.00 | 21.62 |
neurofibroma cell line:Hs 53.T | 10729-110A9 |
715.19 | 0.00 | 11.71 |
neutrophil PMN, donor1 | 12133-128D9 |
208.25 | 0.00 | 0.00 |
neutrophil PMN, donor2 | 12137-128E4 |
677.31 | 0.00 | 0.00 |
neutrophil PMN, donor3 | 12141-128E8 |
842.89 | 0.00 | 0.00 |
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK | 10430-106D7 |
1504.16 | 0.17 | 6.76 |
non-small cell lung cancer cell line:NCI-H1385 | 10730-110B1 |
858.14 | 0.00 | 12.81 |
normal embryonic palatal mesenchymal cell line:HEPM | 10813-111B3 |
898.66 | 0.00 | 9.30 |
normal intestinal epithelial cell line:FHs 74 Int | 10812-111B2 |
820.88 | 0.00 | 3.94 |
nucleus accumbens, adult, pool1 | 10037-101F1 |
286.28 | 0.00 | 3.19 |
occipital cortex - adult, donor10196 | 10172-103C1 |
187.49 | 0.00 | 18.54 |
occipital cortex, adult, donor10252 | 10163-103B1 |
371.95 | 0.00 | 3.22 |
occipital cortex, newborn, donor10223 | 10355-105E4 |
335.56 | 0.00 | 8.01 |
occipital lobe, adult, donor1 | 10076-102A4 |
287.85 | 0.00 | 4.20 |
occipital lobe, fetal, donor1 | 10073-102A1 |
727.75 | 0.00 | 6.44 |
occipital pole, adult, pool1 | 10036-101E9 |
261.36 | 0.00 | 2.44 |
olfactory region, adult | 10195-103E6 |
305.68 | 0.00 | 5.73 |
optic nerve, donor1 | 10277-104E7 |
542.28 | 0.00 | 4.00 |
oral squamous cell carcinoma cell line:Ca9-22 | 10434-106E2 |
1304.36 | 0.57 | 7.18 |
oral squamous cell carcinoma cell line:HO-1-u-1 | 10550-107I1 |
2254.65 | 0.14 | 16.07 |
oral squamous cell carcinoma cell line:HSC-3 | 10545-107H5 |
1321.57 | 0.00 | 7.79 |
oral squamous cell carcinoma cell line:SAS | 10544-107H4 |
1339.67 | 0.00 | 26.57 |
osteoclastoma cell line:Hs 706.T | 10704-109H2 |
530.32 | 0.00 | 3.53 |
osteosarcoma cell line:143B/TK^(-)neo^(R) | 10510-107D6 |
1183.80 | 0.00 | 4.67 |
osteosarcoma cell line:HS-Os-1 | 10558-107I9 |
811.34 | 0.21 | 5.30 |
ovary, adult, pool1 | 10020-101D2 |
931.69 | 0.00 | 1.92 |
pagetoid sarcoma cell line:Hs 925.T | 10732-110B3 |
602.21 | 0.00 | 12.28 |
pancreas, adult, donor1 | 10049-101G4 |
2849.20 | 0.00 | 9.41 |
pancreatic carcinoma cell line:NOR-P1 | 10698-109G5 |
1016.39 | 0.00 | 5.31 |
papillary adenocarcinoma cell line:8505C | 10437-106E5 |
1590.93 | 0.00 | 10.90 |
papillotubular adenocarcinoma cell line:TGBC18TKB | 10417-106C3 |
1054.93 | 0.00 | 5.80 |
paracentral gyrus, adult, pool1 | 10035-101E8 |
232.83 | 0.00 | 2.47 |
parietal cortex, adult, donor10258 | 10373-105G4 |
187.17 | 0.00 | 15.41 |
parietal lobe - adult, donor10196 | 10171-103B9 |
285.91 | 0.00 | 10.35 |
parietal lobe, adult, donor10252 | 10157-103A4 |
297.86 | 0.00 | 2.57 |
parietal lobe, adult, pool1 | 10034-101E7 |
252.20 | 0.09 | 2.91 |
parietal lobe, fetal, donor1 | 10072-101I9 |
1313.16 | 0.00 | 4.85 |
parietal lobe, newborn, donor10223 | 10356-105E5 |
386.57 | 0.00 | 9.72 |
parotid gland, adult | 10199-103F1 |
1157.48 | 0.00 | 4.32 |
penis, adult | 10200-103F2 |
837.89 | 0.00 | 3.76 |
peripheral neuroectodermal tumor cell line:KU-SN | 10697-109G4 |
1099.07 | 0.00 | 2.42 |
pharyngeal carcinoma cell line:Detroit 562 | 10723-110A3 |
1045.80 | 0.00 | 10.20 |
pineal gland - adult, donor10196 | 10179-103C8 |
239.95 | 0.00 | 9.68 |
pineal gland, adult, donor10252 | 10160-103A7 |
315.65 | 0.00 | 0.59 |
pineal gland, adult, donor10258 | 10377-105G8 |
258.35 | 0.00 | 7.52 |
pituitary gland - adult, donor10196 | 10180-103C9 |
493.76 | 0.00 | 16.19 |
pituitary gland, adult, donor10252 | 10162-103A9 |
592.58 | 0.00 | 4.69 |
pituitary gland, adult, donor10258 | 10378-105G9 |
766.12 | 0.00 | 15.32 |
placenta, adult, pool1 | 10021-101D3 |
417.97 | 0.00 | 2.04 |
plasma cell leukemia cell line:ARH-77 | 10840-111E3 |
2423.41 | 0.79 | 23.97 |
pleomorphic hepatocellular carcinoma cell line:SNU-387 | 10706-109H4 |
466.30 | 0.00 | 3.11 |
pons, adult, pool1 | 10033-101E6 |
202.17 | 0.00 | 1.20 |
postcentral gyrus, adult, pool1 | 10032-101E5 |
294.39 | 0.00 | 3.49 |
promyelocytes/myelocytes PMC, donor1 | 12132-128D8 |
1704.49 | 0.00 | 2.09 |
promyelocytes/myelocytes PMC, donor2 | 12136-128E3 |
5750.39 | 0.00 | 11.02 |
promyelocytes/myelocytes PMC, donor3 | 12140-128E7 |
5785.73 | 0.00 | 35.21 |
prostate cancer cell line:DU145 | 10490-107B4 |
1143.74 | 0.15 | 11.07 |
prostate cancer cell line:PC-3 | 10439-106E7 |
691.34 | 0.00 | 4.54 |
prostate, adult, pool1 | 10022-101D4 |
768.07 | 0.00 | 2.45 |
putamen, adult, donor10196 | 10176-103C5 |
457.49 | 0.00 | 4.72 |
putamen, adult, donor10252 | 10152-102I8 |
888.21 | 0.00 | 11.76 |
putamen, adult, donor10258, tech_rep1 | 10372-105G3 |
466.63 | 0.00 | 159.55 |
putamen, adult, donor10258, tech_rep2 | 10372-105G3 |
286.55 | 0.00 | 16.91 |
putamen, newborn, donor10223 | 10365-105F5 |
450.55 | 0.00 | 14.99 |
rectal cancer cell line:TT1TKB | 10469-106I1 |
876.88 | 0.00 | 1.75 |
rectum, fetal, donor1 | 10067-101I4 |
1292.23 | 0.00 | 12.52 |
renal cell carcinoma cell line:OS-RC-2 | 10411-106B6 |
656.13 | 0.00 | 2.54 |
renal cell carcinoma cell line:TUHR10TKB | 10471-106I3 |
601.43 | 0.00 | 3.73 |
retina, adult, pool1 | 10030-101E3 |
512.50 | 0.00 | 1.79 |
retinoblastoma cell line:Y79 | 10475-106I7 |
1581.94 | 0.00 | 12.47 |
rhabdomyosarcoma cell line:KYM-1 | 10787-110H4 |
1086.62 | 0.12 | 26.56 |
rhabdomyosarcoma cell line:RMS-YM | 10477-106I9 |
1781.97 | 0.00 | 16.31 |
sacrococcigeal teratoma cell line:HTST | 10695-109G2 |
855.62 | 0.00 | 0.76 |
salivary acinar cells, donor1 | 11771-123I7 |
909.96 | 0.00 | 7.61 |
salivary acinar cells, donor2 | 11772-123I8 |
1105.90 | 0.14 | 4.41 |
salivary acinar cells, donor3 | 11773-123I9 |
686.55 | 0.00 | 0.66 |
salivary gland, adult, pool1 | 10093-102C3 |
1201.67 | 0.00 | 12.58 |
schwannoma cell line:HS-PSS, tech_rep1 | 10442-106F1 |
504.27 | 0.00 | 2.19 |
schwannoma cell line:HS-PSS, tech_rep2 | 10442-106F1 |
660.99 | 0.00 | 1.65 |
seminal vesicle, adult | 10201-103F3 |
661.34 | 0.00 | 3.70 |
serous adenocarcinoma cell line:JHOS-2 | 10639-108I9 |
1225.07 | 0.00 | 13.60 |
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1 | 11843-124H7 |
690.73 | 0.00 | 17.36 |
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1 | 11841-124H5 |
976.44 | 0.00 | 18.06 |
serous cystadenocarcinoma cell line:HTOA | 10693-109F9 |
745.75 | 0.00 | 4.43 |
signet ring carcinoma cell line:Kato III | 10436-106E4 |
1119.20 | 0.11 | 3.98 |
signet ring carcinoma cell line:NUGC-4 | 10483-107A6 |
1796.93 | 0.13 | 22.19 |
skeletal muscle - soleus muscle, donor1 | 10282-104F3 |
1068.97 | 0.00 | 9.93 |
skeletal muscle, adult, pool1 | 10023-101D5 |
1531.36 | 0.00 | 3.00 |
skeletal muscle, fetal, donor1 | 10066-101I3 |
1782.90 | 0.00 | 9.05 |
skin, adult, donor1 | 10074-102A2 |
1126.34 | 0.00 | 13.57 |
skin, fetal, donor1 | 10065-101I2 |
849.63 | 0.00 | 8.84 |
small cell cervical cancer cell line:HCSC-1 | 10800-110I8 |
2097.53 | 0.00 | 59.37 |
small cell gastrointestinal carcinoma cell line:ECC10 | 10610-108F7 |
1165.63 | 0.00 | 10.09 |
small cell lung carcinoma cell line:DMS 144 | 10841-111E4 |
840.57 | 0.00 | 7.13 |
small cell lung carcinoma cell line:LK-2 | 10541-107H1 |
1696.40 | 0.00 | 13.52 |
small cell lung carcinoma cell line:NCI-H82 | 10842-111E5 |
1593.70 | 0.00 | 7.08 |
small cell lung carcinoma cell line:WA-hT | 10562-108A4 |
736.13 | 0.22 | 14.60 |
small intestine, adult, pool1 | 10024-101D6 |
596.02 | 0.00 | 2.15 |
small intestine, fetal, donor1 | 10064-101I1 |
1261.65 | 0.00 | 4.67 |
small-cell gastrointestinal carcinoma cell line:ECC4 | 10609-108F6 |
992.46 | 0.00 | 5.13 |
smooth muscle, adult, pool1 | 10048-101G3 |
720.06 | 0.00 | 2.07 |
somatostatinoma cell line:QGP-1 | 10781-110G7 |
726.34 | 0.00 | 8.04 |
spinal cord - adult, donor10196 | 10181-103D1 |
392.74 | 0.00 | 2.06 |
spinal cord, adult, donor10252 | 10159-103A6 |
337.50 | 0.00 | 1.18 |
spinal cord, adult, donor10258 | 10369-105F9 |
193.01 | 0.00 | 39.43 |
spinal cord, fetal, donor1 | 10056-101H2 |
573.86 | 0.00 | 3.66 |
spinal cord, newborn, donor10223 | 10359-105E8 |
465.64 | 0.00 | 9.64 |
spindle cell sarcoma cell line:Hs 132.T | 10737-110B8 |
649.69 | 0.00 | 11.05 |
spleen, adult, pool1 | 10025-101D7 |
688.12 | 0.00 | 2.97 |
spleen, fetal, pool1 | 10044-101F8 |
566.44 | 0.00 | 3.97 |
splenic lymphoma with villous lymphocytes cell line:SLVL | 10424-106D1 |
971.98 | 0.00 | 7.04 |
squamous cell carcinoma cell line:EC-GI-10 | 10463-106H4 |
1276.73 | 0.00 | 5.32 |
squamous cell carcinoma cell line:JHUS-nk1 | 10646-109A7 |
483.64 | 0.00 | 5.94 |
squamous cell carcinoma cell line:T3M-5 | 10616-108G4 |
2966.39 | 0.39 | 15.25 |
squamous cell lung carcinoma cell line:EBC-1 | 10486-107A9 |
1161.72 | 0.34 | 9.91 |
squamous cell lung carcinoma cell line:LC-1F | 10457-106G7 |
515.52 | 0.00 | 16.52 |
squamous cell lung carcinoma cell line:RERF-LC-AI | 10501-107C6 |
761.95 | 0.00 | 30.88 |
stomach, fetal, donor1 | 10062-101H8 |
1545.36 | 0.00 | 8.54 |
submaxillary gland, adult | 10202-103F4 |
1080.68 | 0.00 | 3.42 |
substantia nigra - adult, donor10196 | 10178-103C7 |
542.74 | 0.00 | 54.27 |
substantia nigra, adult, donor10252 | 10158-103A5 |
390.07 | 0.00 | 1.87 |
substantia nigra, adult, donor10258 | 10371-105G2 |
109.66 | 0.00 | 27.41 |
substantia nigra, newborn, donor10223 | 10358-105E7 |
515.09 | 0.00 | 9.19 |
synovial sarcoma cell line:HS-SY-II | 10441-106E9 |
696.05 | 0.00 | 9.63 |
temporal lobe, adult, pool1 | 10031-101E4 |
351.03 | 0.00 | 2.97 |
temporal lobe, fetal, donor1, tech_rep1 | 10063-101H9 |
980.08 | 0.00 | 4.99 |
temporal lobe, fetal, donor1, tech_rep2 | 10063-101H9 |
762.16 | 0.00 | 10.11 |
tenocyte, donor1 | 11763-123H8 |
754.41 | 0.00 | 9.77 |
tenocyte, donor2 | 11765-123I1 |
654.66 | 0.00 | 9.92 |
tenocyte, donor3 | 11768-123I4 |
783.59 | 0.00 | 15.94 |
teratocarcinoma cell line:NCC-IT-A3 | 10790-110H7 |
1233.57 | 0.17 | 23.11 |
teratocarcinoma cell line:NCR-G1 | 10798-110I6 |
1815.87 | 0.00 | 29.13 |
teratocarcinoma cell line:PA-1 | 10807-111A6 |
1212.24 | 0.00 | 30.38 |
testicular germ cell embryonal carcinoma cell line:ITO-II | 10786-110H3 |
941.95 | 0.00 | 20.95 |
testicular germ cell embryonal carcinoma cell line:NEC14 | 10591-108D6 |
875.47 | 0.00 | 13.99 |
testicular germ cell embryonal carcinoma cell line:NEC15 | 10593-108D8 |
1132.83 | 0.00 | 3.60 |
testicular germ cell embryonal carcinoma cell line:NEC8 | 10590-108D5 |
1326.59 | 0.00 | 13.03 |
testis, adult, pool1 | 10026-101D8 |
618.79 | 0.00 | 2.90 |
testis, adult, pool2 | 10096-102C6 |
613.48 | 0.00 | 11.73 |
thalamus - adult, donor10196 | 10168-103B6 |
302.49 | 0.00 | 7.73 |
thalamus, adult, donor10252 | 10154-103A1 |
381.33 | 0.00 | 1.88 |
thalamus, adult, donor10258, tech_rep1 | 10370-105G1 |
210.93 | 0.00 | 107.77 |
thalamus, adult, donor10258, tech_rep2 | 10370-105G1 |
331.19 | 0.00 | 4.28 |
thalamus, newborn, donor10223 | 10366-105F6 |
361.88 | 0.00 | 12.08 |
throat, adult | 10209-103G2 |
758.50 | 0.00 | 3.50 |
throat, fetal, donor1 | 10061-101H7 |
988.77 | 0.00 | 5.79 |
thymic carcinoma cell line:Ty-82 | 10803-111A2 |
2267.73 | 0.00 | 23.25 |
thymus, adult, pool1 | 10027-101D9 |
766.79 | 0.00 | 4.97 |
thymus, fetal, pool1 | 10043-101F7 |
569.60 | 0.00 | 3.22 |
thyroid carcinoma cell line:KHM-5M | 10776-110G2 |
1688.60 | 0.53 | 23.40 |
thyroid carcinoma cell line:TCO-1 | 10783-110G9 |
3175.73 | 0.14 | 23.61 |
thyroid, adult, pool1 | 10028-101E1 |
921.84 | 0.00 | 3.45 |
thyroid, fetal, donor1 | 10060-101H6 |
614.86 | 0.00 | 3.43 |
tongue epidermis (fungiform papillae), donor1 | 10288-104F9 |
806.86 | 0.00 | 3.08 |
tongue, adult | 10203-103F5 |
856.58 | 0.00 | 8.14 |
tongue, fetal, donor1 | 10059-101H5 |
1173.61 | 0.00 | 7.88 |
tonsil, adult, pool1 | 10047-101G2 |
1004.86 | 0.00 | 3.91 |
trachea, adult, pool1 | 10029-101E2 |
692.10 | 0.00 | 4.01 |
trachea, fetal, donor1 | 10058-101H4 |
867.49 | 0.00 | 6.92 |
transitional cell carcinoma cell line:Hs 769.T | 10707-109H5 |
914.74 | 0.00 | 15.59 |
transitional-cell carcinoma cell line:5637 | 10418-106C4 |
1059.57 | 0.10 | 8.21 |
transitional-cell carcinoma cell line:JMSU1 | 10492-107B6 |
1360.67 | 0.00 | 4.07 |
tridermal teratoma cell line:HGRT | 10694-109G1 |
1097.76 | 0.00 | 5.71 |
tubular adenocarcinoma cell line:SUIT-2 | 10797-110I5 |
1165.13 | 0.00 | 8.97 |
umbilical cord, fetal, donor1 | 10057-101H3 |
596.74 | 0.00 | 6.26 |
uterus, adult, pool1 | 10100-102D1 |
768.34 | 0.00 | 3.92 |
uterus, fetal, donor1 | 10055-101H1 |
1087.34 | 0.00 | 4.10 |
vagina, adult | 10204-103F6 |
982.22 | 0.00 | 3.23 |
vein, adult | 10191-103E2 |
901.56 | 0.00 | 2.19 |
xeroderma pigentosum b cell line:XPL 17 | 10563-108A5 |
1417.43 | 0.27 | 18.43 |